[{"country": "United States", "city": "South Lyon", "address_1": "350 S Lafayette St", "reason_for_recall": "Lack of Assurance of Sterility: All unexpired sterile compounded human and veterinary products are being recalled because they were compounded in the same environment and under the same practices as another product found to be non-sterile and therefore sterility cannot be assured.", "address_2": "", "product_quantity": "600 mL", "code_info": "All unexpired lots, manufactured and distributed between 07/01/2013 and 10/19/2013; including Lot #: 10032013@2, 10032013@1", "center_classification_date": "20140110", "distribution_pattern": "Hospitals, clinics, physicians, and patients in the Michigan area only.", "state": "MI", "product_description": "POTASSIUM PHOSPHATE* PF 4.4 MEQ (3MM)/mL INJECTABLE, Rx only, Specialty Medicine Compounding Pharmacy, 350 S Lafayette, South Lyon, MI 48178", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Specialty Medicine Compounding Pharmacy", "recall_number": "D-441-2014", "initial_firm_notification": "Press Release", "product_type": "Drugs", "event_id": "66566", "termination_date": "20140922", "more_code_info": "", "recall_initiation_date": "20131019", "postal_code": "48178-1814", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Ferndale", "state": "WA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "67723", "recalling_firm": "Terra-Medica Inc.", "address_1": "1465 Slater Rd", "address_2": "N/A", "postal_code": "98248-8919", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Products were distributed US Nationwide, to Canada, to Philippines, and through internet sales.", "recall_number": "D-1193-2014", "product_description": "Pleo Not CAPSULES 4X, 20 Tablet Cartons, Oral Homeopathic Fever Reducer/ Cough Suppressant/ Decongestant Medicine, OTC Only. Made in Germany, Distributed by: SANUM USA Corp.,1465 Slater Road, Fernadale, WA 98248;  Manufactured By: SANUM-Kehlbeck GmbH & Co. KG. NDC: 49807-2303-1.", "product_quantity": "7408 cartons", "reason_for_recall": "Penicillin Cross Contamination", "recall_initiation_date": "20140303", "center_classification_date": "20140407", "termination_date": "20140730", "report_date": "20140416", "code_info": "Batch # 14010, EXP: December 2014; Batch # 11080, EXP: August 2015;  Batch # 12092, EXP: July 2017."}, {"country": "United States", "city": "Asheville", "address_1": "752 Biltmore Ave", "reason_for_recall": "Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.", "address_2": "", "product_quantity": "", "code_info": "All lot numbers within expiry.", "center_classification_date": "20140304", "distribution_pattern": "NC", "state": "NC", "product_description": "Folic acid (pf) 10mg/cc inj", "report_date": "20140312", "classification": "Class II", "openfda": {}, "recalling_firm": "Natures Pharmacy & Compounding Center", "recall_number": "D-1114-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "66856", "termination_date": "20140424", "more_code_info": "", "recall_initiation_date": "20131101", "postal_code": "28803-2558", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup; MISOPROSTOL Tablet, 100 mcg may be potentially mislabeled as     QUINAPRIL HCL, Tablet, 10 mg, NDC 59762502001, Pedigree: AD42611_4, EXP: 5/14/2014.", "address_2": "", "product_quantity": "120 Tablets", "code_info": "MISOPROSTOL, Tablet, 100 mcg has the following code    Pedigree: AD42611_7, EXP: 5/14/2014.", "center_classification_date": "20140116", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "MISOPROSTOL Tablet, 100 mcg, Rx only, Distributed by: AidaPak Service, LLC, NDC 43386016012", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-564-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65707", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup; PROPRANOLOL HCL Tablet, 80 mg may be potentially mislabeled as    LACTOBACILLUS GG, Capsule, NDC 49100036374, Pedigree: AD42584_12, EXP: 5/14/2014.", "address_2": "", "product_quantity": "100 Tablets", "code_info": "PROPRANOLOL HCL, Tablet, 80 mg has the following code    Pedigree: AD42566_4, EXP: 5/14/2014.", "center_classification_date": "20140116", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "PROPRANOLOL HCL Tablet, 80 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 23155011401", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-532-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65707", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Miami", "state": "FL", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "65383", "recalling_firm": "Dolphin Intertrade Corporation", "address_1": "11314 Sw 135th Ct", "address_2": "N/A", "postal_code": "33186-4425", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide", "recall_number": "D-1249-2014", "product_description": "JaDera, 100% Natural Weight Loss Supplement, capsules,  30 count bottle", "product_quantity": "998 boxes", "reason_for_recall": "Marketed without an Approved NDA/ANDA: Products found to contain undeclared sibutramine. Sibutramine was removed from the U.S. market for safety reasons, making these products unapproved new drugs.", "recall_initiation_date": "20130520", "center_classification_date": "20140418", "termination_date": "20160629", "report_date": "20140430", "code_info": "Manufacturing Codes:  10.06.2011 Exp. 09.06.2013", "more_code_info": ""}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup; CHOLECALCIFEROL, Tablet, 400 units may be potentially mislabeled as     CYANOCOBALAMIN, Tablet, 500 mcg, NDC 00536355101, Pedigree: AD37056_10, EXP: 5/10/2014;  ROSUVASTATIN CALCIUM, Tablet, 5 mg, NDC 00310075590, Pedigree: W002567, EXP: 6/3/2014;  PYRIDOXINE HCL, Tablet, 100 mg, NDC 00536440901, Pedigree: AD76686_4, EXP: 5/31/2014;  CYANOCOBALAMIN, Tablet, 500 mcg, NDC 0053", "address_2": "", "product_quantity": "1,199 Tablets", "code_info": "CHOLECALCIFEROL, Tablet, 400 units has the following codes    Pedigree: AD37056_13, EXP: 5/10/2014;  Pedigree: W002574, EXP: 6/3/2014;  Pedigree: AD76686_7, EXP: 5/31/2014;  Pedigree: AD60578_27, EXP: 5/29/2014;  Pedigree: W003540, EXP: 6/21/2014;  Pedigree: AD52993_25, EXP: 5/20/2014;  Pedigree: W002715, EXP: 6/5/2014;  Pedigree: AD30197_31, EXP: 5/9/2014;  Pedigree: AD73592_8, EXP: 5/31/2014;  Pedigree: W002642, EXP: 6/4/2014.", "center_classification_date": "20140116", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "CHOLECALCIFEROL, Tablet, 400 units, Over The Counter, Distributed by: AidaPak Service, LLC, NDC 00904582360", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-485-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65707", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Aiken", "state": "SC", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["NDA021330"], "brand_name": ["NICORETTE"], "generic_name": ["NICOTINE POLACRILEX"], "manufacturer_name": ["Haleon US Holdings LLC"], "product_ndc": ["0135-0510", "0135-0511"], "product_type": ["HUMAN OTC DRUG"], "route": ["ORAL"], "substance_name": ["NICOTINE"], "rxcui": ["359817", "359818", "968849", "968851"], "spl_id": ["142b2250-8264-423f-e063-6394a90ab05b"], "spl_set_id": ["991704ed-781a-489b-8b56-0b558e8fc385"], "package_ndc": ["0135-0510-01", "0135-0510-06", "0135-0510-07", "0135-0511-01", "0135-0511-06", "0135-0511-07", "0135-0515-03", "30142-862-01", "0363-0209-01", "0363-0209-07"], "is_original_packager": [true], "nui": ["N0000175706", "M0014836"], "pharm_class_epc": ["Cholinergic Nicotinic Agonist [EPC]"], "pharm_class_cs": ["Nicotine [CS]"], "unii": ["6M3C89ZY6R"]}, "product_type": "Drugs", "event_id": "67800", "recalling_firm": "GlaxoSmithKline Consumer Healthcare; dba-GlaxoSmithKline", "address_1": "65 Windham Blvd", "address_2": "N/A", "postal_code": "29805-9384", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S. Nationwide", "recall_number": "D-1240-2014", "product_description": "Nicotine polacrilex lozenge, 4 mg, Original Flavor, 72 count cartons, 81 count cartons, and 108 count cartons. OTC. Labeled a. Nicorette, Distributed By: GlaxoSmithKline Consumer Healthcare, L.P., Moon Township, PA 15108.  Made in Switzerland. 72 Count NDC: 0135-0511-01,108 Count NDC: 0135-0515-03, b. Nicotine Lozenge Kroger,  Lozenge Kroger, Distributed by: The Kroger Company, Cincinnati, Ohio 45202, 72 Count NDC:30142-862-01 and c. Nicotine Walgreens, Distributed by: Walgreen Co., 200 Wilmot Rd., Deerfield, IL 60015. 72 Count NDC: 0363-0209-01, 108 Count NDC: 0363-0209-07.", "product_quantity": "603,696 72 Ct Vials, 191,040 108 Ct Vials", "reason_for_recall": "Failed Lozenge Specifications; Lozenges are overly thick, overly soft, and sub and superpotent.", "recall_initiation_date": "20140220", "center_classification_date": "20140418", "termination_date": "20170120", "report_date": "20140430", "code_info": "Labeled A) 72 Ct Vial: Lot # 13434 (exp 4/14), 13546 (exp 5/14), 13907 (exp 11/14), 14020 (exp 1/15), 14107 (exp 3/15), 14183 (exp 4/15), 14273 (exp 7/15), 14335 (exp 8/15), & 14421 (exp 9/15), 12F27N (exp 4/14), 12K01N (exp 5/14), 13A25N (exp 11/14) & 13C18N (exp 1/15); 108 Ct Vial, Lot # 13383 (exp 4/14), 13626 (exp 5/14), 13725 (exp 10/14), 13861 (exp 12/14), 13980 (exp 1/15), 13982 (exp 1/15), 14091 (exp 4/15), 14153 (exp 5/15), 14227 (exp 7/15), 14262 (exp 7/15), 14318 (exp 8/15), 14371 (exp 8/15) & 14458 (exp 10/15). Labeled B) 72 Ct Vial; Lot # 13924 (exp 12/14),13975 (exp 12/14),14434 (exp 10/15). Labeled C) 72 Ct Vials, Lot #13614 (exp 7/14), 13790 (exp 10/14), 13889 (exp 11/14) & 14018 (exp 12/14), Lot # 13683 (4/17) & 13862 (11/14), 108 Ct Vial, Lot #13726 (exp 10/14) & 13779 (exp 11/14).", "more_code_info": ""}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup; CHOLECALCIFEROL, Tablet, 1000 units may be potentially mislabeled as     ASPIRIN, Chew Tablet, 81 mg, NDC 00536329736, Pedigree: W003459, EXP: 6/20/2014;  MULTIVITAMIN/MULTIMINERAL, Tablet, NDC 37205018581, Pedigree: AD32328_8, EXP: 5/9/2014;  CHOLECALCIFEROL, Tablet, 400 units, NDC 00904582360, Pedigree: W002715, EXP: 6/5/2014;  GLYCOPYRROLATE, Tablet, 2 mg, NDC 49884006601", "address_2": "", "product_quantity": "2,399 Tablets", "code_info": "CHOLECALCIFEROL, Tablet, 1000 units has the following codes    Pedigree: W003464, EXP: 6/20/2014;  Pedigree: AD33897_37, EXP: 5/9/2014;  Pedigree: W002779, EXP: 6/6/2014;  Pedigree: W003626, EXP: 6/25/2014;  Pedigree: W003827, EXP: 6/27/2014;  Pedigree: AD33897_34, EXP: 5/9/2014.", "center_classification_date": "20140116", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "CHOLECALCIFEROL, Tablet, 1000 units, Over The Counter, Distributed by: AidaPak Service, LLC, NDC 00904582460", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-486-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65707", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling:Label Mixup; ATORVASTATIN CALCIUM, Tablet, 80 mg may be potentially mislabeled as    LACTOBACILLUS GG, Capsule, 10 Billion Cells, NDC 49100036374, Pedigree: AD21965_19, EXP: 5/1/2014.", "address_2": "", "product_quantity": "90 Tablets", "code_info": "ATORVASTATIN CALCIUM, Tablet, 80 mg has the following code    Pedigree: AD21965_4, EXP: 5/1/2014.", "center_classification_date": "20140116", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "ATORVASTATIN CALCIUM, Tablet, 80 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 60505267109", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-662-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65707", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Parsippany", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "68407", "recalling_firm": "Ferring Pharmaceuticals Inc", "address_1": "4 Gatehall Dr Fl 3rd", "address_2": "N/A", "postal_code": "07054-4518", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "PA", "recall_number": "D-1385-2014", "product_description": "TEV-TROPIN [somatropin (rDNA origin) for injection] 5 mg (15 IU) 1-count bottle, Rx Only, Manufactured in Israel, Distributed by: Gate Pharmaceuticals div. of Teva Pharmaceuticals USA Sellersville,PA 18960. NDC 57844-713-46", "product_quantity": "129,060 cartons", "reason_for_recall": "Chemical Contamination: TEV-TROPIN [somatropin (rDNA origin) for injection] may contain silicone oil due to leakage of a leaking line during the freeze-drying process.", "recall_initiation_date": "20140428", "center_classification_date": "20140617", "termination_date": "20150806", "report_date": "20140625", "code_info": "Lot # H11599A; Exp. 03/16  Lot # H11599B; Exp. 03/16  Lot # H12913A; Exp. 05/16  Lot # H12913B; Exp. 05/16  Lot # H12914A; Exp. 05/16  Lot # H12914B; Exp. 05/16                Lot # H13846A; Exp. 07/16  Lot # H13846B; Exp. 07/16", "more_code_info": ""}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling:Label Mixup; CALCITRIOL, Capsule, 0.5 mcg may be potentially mislabeled as  NIACIN TR, Tablet, 250 mg, NDC 10939043533, Pedigree: W003756, EXP: 5/31/2014;  ISONIAZID, Tablet, 300 mg, NDC 00555007102, Pedigree: AD32757_28, EXP: 5/13/2014.", "address_2": "", "product_quantity": "500 Capsules", "code_info": "CALCITRIOL, Capsule, 0.5 mcg has the following codes    Pedigree: W003730, EXP: 6/26/2014;  Pedigree: AD32757_10, EXP: 5/14/2014.", "center_classification_date": "20140116", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "CALCITRIOL Capsule, 0.5 mcg, Rx only, Distributed by: AidaPak Service, LLC, NDC 63304024001", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-676-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65707", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup: DOXAZOSIN MESYLATE, Tablet, 1 mg may have potentially been mislabeled as the following drug:  PYRIDOXINE HCL, Tablet, 100 mg, NDC 00536440901, Pedigree: W003872, EXP: 6/27/2014.", "address_2": "", "product_quantity": "100 Tablets", "code_info": "DOXAZOSIN MESYLATE, Tablet, 1 mg has the following codes:   Pedigree: W003912, EXP: 6/28/2014.", "center_classification_date": "20140120", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "DOXAZOSIN MESYLATE, Tablet, 1 mg, Over The Counter, Distributed by: AidaPak Service, LLC, NDC 00093812001.", "report_date": "20140129", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-852-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65690", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Dallas", "state": "TX", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "68345", "recalling_firm": "Abrams Royal Pharmacy", "address_1": "8220 Abrams Rd", "address_2": "N/A", "postal_code": "75231-1402", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Nationwide", "recall_number": "D-0252-2015", "product_description": "Trace Mineral-5 MDV, supplied in 10 mL vials, Each ML contains: 1 mg Zinc (as sulfate), 0.4 mg Copper (as sulfate), 0.1 mg Manganese (as sulfate), 4 mcg Chromium (as chloride), 20 mcg Selenium (as sodium), 0.9% Benzyl alcohol in water for injection, Rx Only, Compounded Medication, ABRAMS ROYAL Compounding Pharmacy, Dallas, TX", "product_quantity": "21 vials", "reason_for_recall": "Non-Sterility; contract laboratory identified Staphylococcus warneri in the product", "recall_initiation_date": "20130513", "center_classification_date": "20141117", "termination_date": "20161007", "report_date": "20141126", "code_info": "Lot number 04302013@21 (also written as 043013-21), exp 10/27/2013"}, {"status": "Terminated", "city": "Naperville", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "69152", "recalling_firm": "Martin Avenue Pharmacy, Inc.", "address_1": "1247 Rickert Dr", "address_2": "N/A", "postal_code": "60540-1008", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide", "recall_number": "D-0168-2015", "product_description": "Vancomycin 25 mg/mL opthalmic solution packaged in an opaque squeeze bottle eye dropper, Martin Avenue Pharmacy, 1247 Rickert Dr, Naperville, IL.", "product_quantity": "20  mL", "reason_for_recall": "Lack of Assurance of Sterility: Martin Avenue Pharmacy, Inc. is conducting a voluntary recall of all compounded sterile preparations within expiry. The recall is being initiated in connection with a recent FDA inspection due to observations associated with certain quality control procedures that present a risk to sterility assurance.", "recall_initiation_date": "20140827", "center_classification_date": "20141029", "termination_date": "20180531", "report_date": "20141105", "code_info": "Lot Number: 06102014@40, Exp 9/8/2014", "more_code_info": ""}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup: CALCIUM/ CHOLECALCIFEROL/ SODIUM, Tablet, 600 mg/400 units/5 mg may have potentially been mislabeled as one of the following drugs:  CALCIUM ACETATE, Capsule, 667 mg, NDC 00054008826, Pedigree: W003460, EXP: 6/20/2014;  OMEGA-3 FATTY ACID, Capsule, 1000 mg, NDC 40985022921, Pedigree: AD60240_1, EXP: 5/22/2014.", "address_2": "", "product_quantity": "720 Tablets", "code_info": "CALCIUM/ CHOLECALCIFEROL/ SODIUM, Tablet, 600 mg/400 units/5 mg has the following codes:   Pedigree: W003461, EXP: 6/20/2014;  Pedigree: AD60428_1, EXP: 5/22/2014.", "center_classification_date": "20140120", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "CALCIUM/ CHOLECALCIFEROL/ SODIUM, Tablet, 600 mg/400 units/5 mg, Over The Counter, Distributed by: AidaPak Service, LLC, NDC 00536342408.", "report_date": "20140129", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-929-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65690", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Naperville", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "69152", "recalling_firm": "Martin Avenue Pharmacy, Inc.", "address_1": "1247 Rickert Dr", "address_2": "N/A", "postal_code": "60540-1008", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide", "recall_number": "D-0102-2015", "product_description": "Methylcobalamin (PF) 25 mg/mL injectable packaged in an amber glass injectable vial, Martin Avenue Pharmacy, 1247 Rickert Dr, Naperville, IL.", "product_quantity": "50 mL", "reason_for_recall": "Lack of Assurance of Sterility: Martin Avenue Pharmacy, Inc. is conducting a voluntary recall of all compounded sterile preparations within expiry. The recall is being initiated in connection with a recent FDA inspection due to observations associated with certain quality control procedures that present a risk to sterility assurance.", "recall_initiation_date": "20140827", "center_classification_date": "20141029", "termination_date": "20180531", "report_date": "20141105", "code_info": "Lot Number: 04092014@14, Exp 10/6/2014", "more_code_info": ""}, {"status": "Terminated", "city": "Livonia", "state": "MI", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "68532", "recalling_firm": "Central Admixture Pharmacy Services, Inc.", "address_1": "37497 Schoolcraft Rd", "address_2": "N/A", "postal_code": "48150-1007", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Michigan and Wisconsin", "recall_number": "D-1561-2014", "product_description": "adenosine 90 mg in 0.9% sodium chloride/90 mL, Rx Only, Central Admixture Pharmacy Services, Inc., Livonia, MI 48150", "product_quantity": "5 doses", "reason_for_recall": "Non Sterility; microbial contamination identified as Aspergillus species", "recall_initiation_date": "20140528", "center_classification_date": "20140825", "termination_date": "20140919", "report_date": "20140903", "code_info": "Lot# 13-920757-0-1 through Lot# 13-920757-0-5 (5 total doses)  EXP 06 JUL 2014"}, {"status": "Terminated", "city": "Phoenix", "state": "AZ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "69405", "recalling_firm": "Avella of Deer Valley, Inc.", "address_1": "23620 N 20th Dr Ste 12", "address_2": "N/A", "postal_code": "85085-0621", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Nationwide", "recall_number": "D-0016-2014", "product_description": "HYDROXYPROGESTERONE CAPROATE 250 MG/ML (IN SESAME OIL), Rx Only 4 mL INJECTABLE IM USE. Manufactured by Avella Specialty Pharmacy, Phoenix, AZ 85085.", "product_quantity": "197 vials", "reason_for_recall": "Crystallization: Formation of crystals observed in product.", "recall_initiation_date": "20141001", "center_classification_date": "20141010", "termination_date": "20150220", "report_date": "20141022", "code_info": "Lot#  12-20140207@109; Exp. 12/14    Lot#  12-20142107@82;   Exp.  01/15"}, {"status": "Terminated", "city": "Horsham", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "67412", "recalling_firm": "Teva Pharmaceuticals USA", "address_1": "425 Privet Rd", "address_2": "", "postal_code": "19044-1220", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide.", "recall_number": "D-1092-2014", "product_description": "Teva Ethambutol Hydrochloride Tablets, USP, 400 mg, 100- count bottle, Rx Only,Distributed by Teva Pharmaceuticals, USA, Sellersville, PA., NDC 0555-0923-02.", "product_quantity": "10405 tablets", "reason_for_recall": "CGMP Deviations: Ethambutol Hydrochloride Tablets, USP, 400 mg were manufactured using unapproved material: the incorrect gelatin excipient than specified in the product formulation.", "recall_initiation_date": "20140124", "center_classification_date": "20140228", "termination_date": "20141008", "report_date": "20140312", "code_info": "Lot # 34013698A, Exp.  01/16.  Lot #  34013699A, Exp. 01/16.  Lot #  34013700A, Exp. 01/16.  Lot #  34013756A, Exp. 01/16.", "more_code_info": ""}, {"country": "United States", "city": "Horsham", "address_1": "425 Privet Rd", "reason_for_recall": "Failed Impurities/Degradation Specifications:There is a potential for the tablets to be out of specification for impurities throughout shelf life.", "address_2": "", "product_quantity": "1,249,700 tablets", "code_info": "lot #14071112AA; Exp. 03/14.   lot #14071112AB;  Exp. 03/14.   lot # 14071012BA;  Exp. 03/14.  lot #14071012BB;  Exp 03/14.", "center_classification_date": "20140204", "distribution_pattern": "Nationwide", "state": "PA", "product_description": "Hydralazine HCL Tablets, USP, 25 mg in a single blister package, Manufactured in Czech Republic By: Teva Czech Industries s.r.o. Opava-Komarov, Czech Republic, Distributed by Goldline Laboratories, Sellersville, PA, NDC 00182-0554-89  (carton) and 00182-0554-00 (single blister).", "report_date": "20140212", "classification": "Class II", "openfda": {}, "recalling_firm": "Teva Pharmaceuticals USA", "recall_number": "D-1074-2014", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "67141", "termination_date": "20141022", "more_code_info": "", "recall_initiation_date": "20131218", "postal_code": "19044-1220", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Pennington", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA076900"], "brand_name": ["ATENOLOL"], "generic_name": ["ATENOLOL"], "manufacturer_name": ["Zydus Pharmaceuticals USA Inc."], "product_ndc": ["68382-022", "68382-023", "68382-024"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["ATENOLOL"], "rxcui": ["197379", "197380", "197381"], "spl_id": ["860eb406-b330-4b72-b768-122d57c74293"], "spl_set_id": ["db801706-1362-44c7-92ab-f584f96c7e1c"], "package_ndc": ["68382-022-16", "68382-022-01", "68382-022-10", "68382-022-40", "68382-022-24", "68382-023-16", "68382-023-01", "68382-023-10", "68382-023-02", "68382-023-40", "68382-023-24", "68382-024-16", "68382-024-01", "68382-024-10", "68382-024-40"], "is_original_packager": [true], "nui": ["N0000000161", "N0000175556"], "pharm_class_moa": ["Adrenergic beta-Antagonists [MoA]"], "pharm_class_epc": ["beta-Adrenergic Blocker [EPC]"], "unii": ["50VV3VW0TI"]}, "product_type": "Drugs", "event_id": "68988", "recalling_firm": "Zydus Pharmaceuticals USA Inc", "address_1": "73 Route 31 N", "address_2": "", "postal_code": "08534-3601", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0007-2015", "product_description": "ZyGenerics ATENOLOL Tablets, USP 25 mg 1000 count bottle, Rx Only Manufactured by: Cadila Healthcare Ltd. Ahmedabad, India Distributed by: Zydus Pharmaceuticals USA Inc. Pennington, NJ 08634 USA  NDC 68382-022-01", "product_quantity": "5400 bottles", "reason_for_recall": "Superpotent Drug: A complaint was reported by a pharmacist who stated several tablets  were noticeably thicker in appearance.", "recall_initiation_date": "20140805", "center_classification_date": "20141003", "termination_date": "20170922", "report_date": "20141015", "code_info": "MP2292 Exp. 01/16", "more_code_info": ""}, {"status": "Terminated", "city": "Naperville", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "69152", "recalling_firm": "Martin Avenue Pharmacy, Inc.", "address_1": "1247 Rickert Dr", "address_2": "N/A", "postal_code": "60540-1008", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide", "recall_number": "D-0115-2015", "product_description": "PGE 4, 300 mcg/mL injectable packaged in a clear glass injectable vial, Martin Avenue Pharmacy, 1247 Rickert Dr, Naperville, IL.", "product_quantity": "60 mL", "reason_for_recall": "Lack of Assurance of Sterility: Martin Avenue Pharmacy, Inc. is conducting a voluntary recall of all compounded sterile preparations within expiry. The recall is being initiated in connection with a recent FDA inspection due to observations associated with certain quality control procedures that present a risk to sterility assurance.", "recall_initiation_date": "20140827", "center_classification_date": "20141029", "termination_date": "20180531", "report_date": "20141105", "code_info": "Lot Number: 08062014@40, Exp 11/4/2014", "more_code_info": ""}, {"country": "United States", "city": "Nashville", "address_1": "110 20th Ave N", "reason_for_recall": "Presence of Particulate Matter", "address_2": "", "product_quantity": "3 vials", "code_info": "Lot #: 641:07, Expiry: 8/11/14", "center_classification_date": "20140425", "distribution_pattern": "MO, TN, MS, WI", "state": "TN", "product_description": "Polidocanol 3% Solution, 50 mL Vial, Rx Only, Not for Resale. John Hollis Pharmacy, 110 20th Avenue N, Nashville, TN 37203.", "report_date": "20140507", "classification": "Class II", "openfda": {}, "recalling_firm": "John W Hollis Inc", "recall_number": "D-1260-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "67812", "termination_date": "20140501", "more_code_info": "", "recall_initiation_date": "20140317", "postal_code": "37203-2315", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Lake Forest", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "69494", "recalling_firm": "Hospira Inc.", "address_1": "275 N Field Dr", "address_2": "N/A", "postal_code": "60045-2579", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide, Puerto Rico, and U.S. Virgin Islands.", "recall_number": "D-0281-2015", "product_description": "Lactated Ringer's and 5% Dextrose Injection, USP; 1000 mL container, Rx Only, Manufactured by Hospira, Inc., Lake Forest, IL 60045  NDC 0409-7929-09.", "product_quantity": "275,448 bags", "reason_for_recall": "Lack of Assurance of Sterility: Potential of punctures through the overwrap and primary container which may result in IV bag leaks.", "recall_initiation_date": "20141014", "center_classification_date": "20141125", "termination_date": "20151228", "report_date": "20141203", "code_info": "Lot # 34-134-JT Exp. 10/15  Lot # 34-166-JT Exp. 10/15", "more_code_info": ""}, {"status": "Terminated", "city": "Titusville", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA021346"], "brand_name": ["RISPERDAL CONSTA"], "generic_name": ["RISPERIDONE"], "manufacturer_name": ["Janssen Pharmaceuticals, Inc."], "product_ndc": ["50458-306", "50458-309", "50458-307", "50458-308"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "rxcui": ["402010", "402011", "402012", "706822", "706825", "706827", "706829", "706831"], "spl_id": ["42dc490b-4117-142a-e063-6294a90aeb21"], "spl_set_id": ["bb34ee82-d2c2-43b8-ba21-2825c0954691"], "package_ndc": ["50458-309-11", "50458-309-01", "50458-306-11", "50458-306-01", "50458-307-11", "50458-307-01", "50458-308-11", "50458-308-01"], "is_original_packager": [true]}, "product_type": "Drugs", "event_id": "66261", "recalling_firm": "Janssen Pharmaceuticals, Inc.", "address_1": "1125 Trenton Harbourton Rd", "address_2": "N/A", "postal_code": "08560-1503", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide", "recall_number": "D-1514-2014", "product_description": "Risperdal CONSTA  (risperiDONE),  25 mg Dose Pack, Rx Only, Single Use Only Janssen Pharmaceuticals Inc., Titusville, NJ 08560  NDC 50458-306-11", "product_quantity": "70,495 kits", "reason_for_recall": "Non-Sterility: Janssen  is recalling  one lot of Risperdal CONSTA (risperiDONE)   due to a sterility failure in a  stability sample", "recall_initiation_date": "20130911", "center_classification_date": "20140805", "termination_date": "20150123", "report_date": "20140813", "code_info": "Vial - 4212AAP1, Kit - 309316, Exp. 07/15"}, {"country": "United States", "city": "Tampa", "address_1": "2631 Causeway Center Dr", "reason_for_recall": "Labeling: Not Elsewhere Classified: Label indicates that the product contains Vitamin B12 (12 micrograms) on the Supplement Facts panel, however, the formulation of this product does not contain Vitamin B12.", "address_2": "", "product_quantity": "142,732 bottles", "code_info": "Lot #: 505024006, 505024007, Exp 03/15; 505024008; 505024009, Exp 06/15; 505024010, Exp 08/15; 505024011, Exp 09/15; and 505024012, Exp 10/15", "center_classification_date": "20140819", "distribution_pattern": "Nationwide", "state": "FL", "product_description": "Triveen - PRx RNF Capsules, 30-count bottles, Rx only; Manufactured for: Trigen Laboratories, Inc., Sayreville, NJ  08872, NDC 13811-558-30, UPC 3 13811 55830 2.", "report_date": "20140827", "classification": "Class III", "openfda": {}, "recalling_firm": "Trigen Laboratories, Inc.", "recall_number": "D-1544-2014", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "product_type": "Drugs", "event_id": "68685", "termination_date": "20170726", "more_code_info": "", "recall_initiation_date": "20140417", "postal_code": "33619-6102", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Overland Park", "state": "KS", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "69674", "recalling_firm": "Perry Drug Inc.", "address_1": "12200 W 106th St Ste 140", "address_2": "N/A", "postal_code": "66215-2305", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Kansas and Missouri", "recall_number": "D-0265-2015", "product_description": "HCG Low Dose 30 IU/0.1 mL, 5 Ml vial, Compounded Rx, Perry Drug Compounding Pharmacy, Overland Park, KS --- NDC 88888-0231-54", "product_quantity": "1 vial", "reason_for_recall": "Lack of sterility assurance;All lots of sterile products compounded by the pharmacy that are within expiry were recalled due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.", "recall_initiation_date": "20141107", "center_classification_date": "20141124", "termination_date": "20151103", "report_date": "20141203", "code_info": "141009DD, 11/9/14", "more_code_info": ""}, {"status": "Terminated", "city": "Levittown", "state": "PA", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "68218", "recalling_firm": "Eugene Oregon, Inc.", "address_1": "54 Spinythorn  Road", "address_2": "N/A", "postal_code": "19056", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "To retailers in MD, TX, FL, PA, IL, NJ, IN, LA, WA, ME, SC", "recall_number": "D1612-2014", "product_description": "AFRICAN BLACK ANT, 2800 mg, 6 capsules per box, produced by: Qinghan Hongwei Bioengineering Company, No. 158, Renmin Road, Xining City.", "product_quantity": "460 boxes", "reason_for_recall": "Marketed Without an Approved NDA/ANDA: Eugene FDA laboratory analyses determined they contain undeclared sildenafil.", "recall_initiation_date": "20140505", "center_classification_date": "20140929", "termination_date": "20150401", "report_date": "20141008", "code_info": "All lots"}, {"status": "Terminated", "city": "Salisbury", "state": "MD", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA201845"], "brand_name": ["LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE"], "generic_name": ["LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE"], "manufacturer_name": ["Jubilant Cadista Pharmacuticals Inc."], "product_ndc": ["59746-337", "59746-338", "59746-339"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["HYDROCHLOROTHIAZIDE", "LOSARTAN POTASSIUM"], "rxcui": ["979464", "979468", "979471"], "spl_id": ["254a3da5-afd8-4a49-86d3-e347868cb906"], "spl_set_id": ["e0b74a86-3d36-1af0-e538-41b45b8d2cc3"], "package_ndc": ["59746-337-30", "59746-337-90", "59746-337-01", "59746-337-10", "59746-338-30", "59746-338-90", "59746-338-01", "59746-338-10", "59746-339-30", "59746-339-90", "59746-339-01", "59746-339-10"], "is_original_packager": [true], "upc": ["0359746339302", "0359746337308", "0359746338305"], "nui": ["N0000175359", "N0000175419", "M0471776"], "pharm_class_pe": ["Increased Diuresis [PE]"], "pharm_class_epc": ["Thiazide Diuretic [EPC]"], "pharm_class_cs": ["Thiazides [CS]"], "unii": ["0J48LPH2TH", "3ST302B24A"]}, "product_type": "Drugs", "event_id": "68776", "recalling_firm": "Jubilant Cadista Pharmaceuticals Inc.", "address_1": "207 Kiley Dr", "address_2": "", "postal_code": "21801-2249", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Nationwide and Puerto Rico", "recall_number": "D-1500-2014", "product_description": "Losartan Potassium and Hydrochlorothiazide Tablets, USP 100 mg/25 mg, 90-tablets per bottle, Rx Only, Manufactured by: Jubilant Cadista Pharmaceuticals Inc., Salisbury, MD 21801, NDC # 59746-339-90", "product_quantity": "9,358 bottles", "reason_for_recall": "Presence of Foreign Substance: Tablets may contain dark blemishes identified as stainless steel.", "recall_initiation_date": "20140711", "center_classification_date": "20140731", "termination_date": "20160915", "report_date": "20140806", "code_info": "Lot #14P0292, Exp 04/2016", "more_code_info": ""}, {"status": "Terminated", "city": "Greenville", "state": "SC", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "69547", "recalling_firm": "Pharmaceutical Associates Inc", "address_1": "201 Delaware St", "address_2": "N/A", "postal_code": "29605-5823", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0240-2015", "product_description": "Cyproheptadine HCl Syrup (Cyproheptadine HCl Oral Solution, USP) 4mg/10 mL, Rx ONLY, Pharmaceutical Associates, Inc., Greenville, SC 29605, NDC 0121-4788-10", "product_quantity": "9,640 unit dose cups", "reason_for_recall": "Failed Impurities/Degradation Specifications : Out-of-specification result for an unidentified impurity at the 12 month stability test point.", "recall_initiation_date": "20141016", "center_classification_date": "20141106", "termination_date": "20170614", "report_date": "20141112", "code_info": "Lot 3H43, Exp. 02/15"}, {"status": "Terminated", "city": "Clive", "state": "IA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "68626", "recalling_firm": "Medical Supply Liquidators Llc", "address_1": "10500 Hickman Rd Ste F", "address_2": "N/A", "postal_code": "50325-3706", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide and Foriegn distribution was made to Canada, United Kingdom, Australia, Slovenia, Germany, Spain, Finland and Croatia.", "recall_number": "D-1528-2014", "product_description": "B Complex for Injection USP with Methylcobalamin 1000 mcg/ml, Sterile, for IM or Deep SQ use, multiple dose vial, packaged in 10 ml vials and 30 ml vials. Manufactured by: CB Inc. for Sunshine Labs, www.sunshinelabs.us.", "product_quantity": "N/A", "reason_for_recall": "Marketed without an Approved NDA/ANDA; IM and SQ injectable products are being recalled because the manufacturing firm is not registered with the FDA as a drug manufacturer", "recall_initiation_date": "20140625", "center_classification_date": "20140806", "termination_date": "20170314", "report_date": "20140813", "code_info": "All lot numbers and exp dates"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling:Label Mixup; LETROZOLE Tablet, 2.5 mg may be potentially mislabeled as    METOPROLOL TARTRATE, Tablet, 50 mg, NDC 00093073301, Pedigree: W003848, EXP: 6/27/2014.", "address_2": "", "product_quantity": "30 Tablets", "code_info": "LETROZOLE, Tablet, 2.5 mg has the following code    Pedigree: W003868, EXP: 6/27/2014.", "center_classification_date": "20140116", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "LETROZOLE Tablet, 2.5 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 62756051183", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-675-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65707", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Toronto", "state": "N/A", "country": "Canada", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "69546", "recalling_firm": "Apotex Inc.", "address_1": "150 Signet Drive", "address_2": "N/A", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide.", "recall_number": "D-0243-2015", "product_description": "Candesartan Cilexetil Tablets, 16 mg, a) 30-count bottle (NDC 60505-3620-3) b) 90-count bottles (NDC 60505-3620-9) Rx Only, Manufactured by Apotex Research Pvt. Ltd., Bangalore- 560 099, India, Manufactured for Apotex Corp., Weston, FL 33326", "product_quantity": "11,062 bottles", "reason_for_recall": "Failed Impurities/Degradation Specifications: Out of specification (OOS) results were observed for CAD-II, CAD-V and Total Impurities.", "recall_initiation_date": "20141016", "center_classification_date": "20141106", "termination_date": "20160930", "report_date": "20141112", "code_info": "Lot #: a) KR3943; Exp. 11/15  Lot #: b) KT6058, KT6060; Exp. Date 11/15"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling:Label Mixup; QUEtiapine FUMARATE, Tablet, 25 mg may be potentially mislabeled as    MULTIVITAMIN/MULTIMINERAL, Chew Tablet, NDC 58914001460, Pedigree: AD32325_1, EXP: 5/9/2014;  ASPIRIN DR EC, Tablet, 81 mg, NDC 00182106105, Pedigree: W003094, EXP: 6/13/2014.", "address_2": "", "product_quantity": "400 Tablets", "code_info": "QUEtiapine FUMARATE, Tablet, 25 mg has the following codes    Pedigree: AD33897_25, EXP: 5/9/2014;  Pedigree: W003099, EXP: 6/13/2014.", "center_classification_date": "20140116", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "QUEtiapine FUMARATE, Tablet, 25 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 60505313001", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-664-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65707", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup: LITHIUM CARBONATE ER, Tablet, 450 mg may be potentially mislabled as one of the following drugs:   HYOSCYAMINE SULFATE SL, Tablet, 0.125 mg, NDC 00574025001, Pedigree: AD21790_19, EXP: 5/1/2014;  LACTOBACILLUS ACIDOPHILUS, Capsule, 500 MILLION CFU, NDC 43292050022, Pedigree: AD46257_28, EXP: 5/15/2014;  HYDROCORTISONE, Tablet, 5 mg, NDC 00603389919, Pedigree: W002729, EXP: 6", "address_2": "", "product_quantity": "1899 Tablets", "code_info": "LITHIUM CARBONATE ER, Tablet, 450 mg has the following codes:   Pedigree: AD21790_28, EXP: 5/1/2014  Pedigree: AD46265_10, EXP: 5/15/2014  Pedigree: W002730, EXP: 6/6/2014  Pedigree: W003681, EXP: 6/25/2014  Pedigree: AD60272_25, EXP: 5/22/2014  Pedigree: AD62796_1, EXP: 5/22/2014  Pedigree: W003327, EXP: 6/19/2014.", "center_classification_date": "20140120", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "LITHIUM CARBONATE ER, Tablet, 450 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00054002025.", "report_date": "20140129", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-790-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65690", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Naperville", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "69152", "recalling_firm": "Martin Avenue Pharmacy, Inc.", "address_1": "1247 Rickert Dr", "address_2": "N/A", "postal_code": "60540-1008", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide", "recall_number": "D-0071-2015", "product_description": "Cromolyn sodium 1% inhalant solution packaged in a 3 mL or 7 mL vial,  Martin Avenue Pharmacy, 1247 Rickert Dr, Naperville, IL.", "product_quantity": "190 mL", "reason_for_recall": "Lack of Assurance of Sterility: Martin Avenue Pharmacy, Inc. is conducting a voluntary recall of all compounded sterile preparations within expiry. The recall is being initiated in connection with a recent FDA inspection due to observations associated with certain quality control procedures that present a risk to sterility assurance.", "recall_initiation_date": "20140827", "center_classification_date": "20141029", "termination_date": "20180531", "report_date": "20141105", "code_info": "Lot Number: 08062014@24, Exp 11/4/2014", "more_code_info": ""}, {"status": "Terminated", "city": "Naperville", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "69152", "recalling_firm": "Martin Avenue Pharmacy, Inc.", "address_1": "1247 Rickert Dr", "address_2": "N/A", "postal_code": "60540-1008", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide", "recall_number": "D-0093-2015", "product_description": "Hydroxocobalamin 10 mg/mL injectable packaged in an amber glass injectable vial, Martin Avenue Pharmacy, 1247 Rickert Dr, Naperville, IL.", "product_quantity": "32 mL", "reason_for_recall": "Lack of Assurance of Sterility: Martin Avenue Pharmacy, Inc. is conducting a voluntary recall of all compounded sterile preparations within expiry. The recall is being initiated in connection with a recent FDA inspection due to observations associated with certain quality control procedures that present a risk to sterility assurance.", "recall_initiation_date": "20140827", "center_classification_date": "20141029", "termination_date": "20180531", "report_date": "20141105", "code_info": "Lot Number: 07232014@15, Exp 10/21/2014", "more_code_info": ""}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup; PRENATAL MULTIVITAMIN/ MULTIMINERAL, Tablet may be potentially mislabeled as    COLCHICINE, Tablet, 0.6 mg, NDC 64764011907, Pedigree: AD65457_1, EXP: 5/23/2014;  GALANTAMINE HBr ER, Capsule, 8 mg, NDC 10147089103, Pedigree: W003509, EXP: 6/21/2014;  BROMOCRIPTINE MESYLATE, Tablet, 2.5 mg, NDC 00781532531, Pedigree: AD32579_7, EXP: 5/9/2014;  CINACALCET HCL, Tablet, 30 mg, N", "address_2": "", "product_quantity": "1,399 Tablets", "code_info": "PRENATAL MULTIVITAMIN/ MULTIMINERAL, Tablet has the following codes    Pedigree: AD62829_18, EXP: 5/24/2014;  Pedigree: W003511, EXP: 6/21/2014;  Pedigree: AD32579_4, EXP: 5/9/2014;  Pedigree: AD73597_16, EXP: 5/31/2014;  Pedigree: W003086, EXP: 6/12/2014;  Pedigree: W003034, EXP: 6/12/2014.", "center_classification_date": "20140116", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "PRENATAL MULTIVITAMIN/ MULTIMINERAL, Tablet, Over The Counter, Distributed by: AidaPak Service, LLC, NDC 51991056601", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-606-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65707", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Ocala", "address_1": "202 SW 17th St Suite C", "reason_for_recall": "Lack of Assurance of Sterility; All lots of sterile products compounded by the pharmacy within expiry are subject to this recall. This recall is initiated due to concerns associated with quality control procedures observed during a recent FDA inspection.", "address_2": "", "product_quantity": "1 unit", "code_info": "Rx # 28838, Exp 03/4/15", "center_classification_date": "20140724", "distribution_pattern": "Florida", "state": "FL", "product_description": "ANA Kit, Trinity Care Solutions, 202-C SW 17th Street, Ocala, FL 34471-5138, For Parenteral Use Only, Rx # 28838, Discard After 03/4/15", "report_date": "20140730", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc dba Trinity Care Solutions", "recall_number": "D-1470-2014", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "product_type": "Drugs", "event_id": "68497", "more_code_info": "", "recall_initiation_date": "20140515", "postal_code": "34471-8138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Ongoing"}, {"status": "Terminated", "city": "Toronto", "state": "", "country": "Canada", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "68967", "recalling_firm": "Apotex Inc.", "address_1": "150 Signet Drive", "address_2": "", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide and Puerto Rico", "recall_number": "D-1575-2014", "product_description": "PAXIL  (Paroxetine HCL) Oral Suspension 10 mg/5 mL - 250 mL bottle, Rx Only, Manufactured by GlaxoSmithKline, RTP, NC 27709. Distributed by Apotex Corp., Westin, FL 33326, NDC 60505-0402-5", "product_quantity": "13,429 bottles", "reason_for_recall": "Chemical Contamination: Product were manufactured with active pharmaceutical ingredient (API) batches contaminated with residual materials and solvents.", "recall_initiation_date": "20140324", "center_classification_date": "20140903", "termination_date": "20140923", "report_date": "20140910", "code_info": "Lot # 2A001,  Exp. 01/15; Lot # 2C002, Exp. 03/15", "more_code_info": ""}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup; PROPRANOLOL HCL, Tablet, 10 mg may be potentially mislabeled as    PERPHENAZINE, Tablet, 16 mg, NDC 00781104901, Pedigree: AD21790_31, EXP: 5/1/2014;  buPROPion HCl ER (XL), Tablet, 150 mg, NDC 67767014130, Pedigree: AD52412_4, EXP: 4/30/2014;  MULTIVITAMIN/MULTIMINERAL LOW IRON, Tablet, NDC 64376081601, Pedigree: AD60272_31, EXP: 5/22/2014;  PERPHENAZINE, Tablet, 16 mg, NDC", "address_2": "", "product_quantity": "2,299 Tablets", "code_info": "PROPRANOLOL HCL Tablet, 10 mg has the following codes    Pedigree: AD21790_34, EXP: 5/1/2014;  Pedigree: AD52390_1, EXP: 5/17/2014;  Pedigree: AD60272_37, EXP: 5/22/2014;  Pedigree: W002732, EXP: 6/6/2014;  Pedigree: W003229, EXP: 6/17/2014;  Pedigree: AD60272_34, EXP: 5/22/2014;  Pedigree: W003684, EXP: 6/25/2014;  Pedigree: W002618, EXP: 6/4/2014;  Pedigree: W003002, EXP: 6/11/2014;  Pedigree: W003068, EXP: 6/12/2014;  Pedigree: W003545, EXP: 6/21/2014.", "center_classification_date": "20140116", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "PROPRANOLOL HCL Tablet, 10 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 23155011001", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-529-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65707", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Conway", "address_1": "1270 Don's Lane", "reason_for_recall": "Labeling: Label Error on Declared Strength; The outer light protective bags, where the ephedrine sulfate injection syringes are stored, were mislabeled with 25 mg/mL in big font and 5 mg/mL in small font, however, the actual syringes were correctly labeled as 25 mg/5 mL.", "address_2": "", "product_quantity": "762 Syringes", "code_info": "Lot# 20142104@30  USE BY: 10/18/2014", "center_classification_date": "20140820", "distribution_pattern": "Nationwide", "state": "AR", "product_description": "ePHEDrine Sulfate Injection, USP 25 mg/5 mL (5 mg/mL)  Single Use 5 mL Syringe, For IV, IM, or SC injection, Preservative Free, For Office/Hospital Use Only, Protect from Light,  62295-3084-05, US Compounding Pharmacy, Conway, AR 800-718-3588", "report_date": "20140827", "classification": "Class II", "openfda": {}, "recalling_firm": "US Compounding Inc", "recall_number": "D-1548-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "68336", "termination_date": "20141104", "more_code_info": "", "recall_initiation_date": "20140516", "postal_code": "72032", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Clive", "state": "IA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "68626", "recalling_firm": "Medical Supply Liquidators Llc", "address_1": "10500 Hickman Rd Ste F", "address_2": "N/A", "postal_code": "50325-3706", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide and Foriegn distribution was made to Canada, United Kingdom, Australia, Slovenia, Germany, Spain, Finland and Croatia.", "recall_number": "D-1525-2014", "product_description": "MIC Injection USP, Sterile, 10 ml vial and 30 ml vial, For IM or Deep SQ Use, Multiple Dose Vial, Manufactured by: CB Inc. for Sunshine Labs, www.sunshinelabs.us", "product_quantity": "N/A", "reason_for_recall": "Marketed without an Approved NDA/ANDA; IM and SQ injectable products are being recalled because the manufacturing firm is not registered with the FDA as a drug manufacturer", "recall_initiation_date": "20140625", "center_classification_date": "20140806", "termination_date": "20170314", "report_date": "20140813", "code_info": "All lot numbers and exp dates"}, {"status": "Terminated", "city": "Mesa", "state": "AZ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "67080", "recalling_firm": "Zions RX Formulations Services LLC dba RX Formuations Serv.", "address_1": "5949 E University Dr", "address_2": "N/A", "postal_code": "85205-7435", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "AZ", "recall_number": "D-1215-2014", "product_description": "Potassium Phosphates 4.4mEq/3mM/mL Vials, Not for Dispensing, For Hospital Administration Only, Rx Formulations, 5949 East University Drive, Mesa, AZ 85205", "product_quantity": "95 Vials", "reason_for_recall": "Lack of Assurance of Sterility: The firm expanded the recall to other injectable products due to lack of assurance of sterility from poor aseptic practices observed at the firm.", "recall_initiation_date": "20131212", "center_classification_date": "20140407", "termination_date": "20140501", "report_date": "20140416", "code_info": "Lot #: 117467@9 Expiration Date: 12/12/2013   Lot #: 117857@2 Expiration Date: 12/15/2013   Lot #: 117740@4 Expiration Date: 12/13/2013"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup; NICOTINE POLACRILEX Gum, 2 mg may be potentially mislabeled as    SACCHAROMYCES BOULARDII LYO, Capsule, 250 mg, NDC 00414200007, Pedigree: AD54586_4, EXP: 5/21/2014.", "address_2": "", "product_quantity": "50 Pieces of Gum", "code_info": "NICOTINE POLACRILEX Gum, 2 mg has the following code    Pedigree: AD54586_7, EXP: 3/31/2014.", "center_classification_date": "20140116", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "NICOTINE POLACRILEX Gum, 2 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 24385059471", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-538-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65707", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup:TRIHEXYPHENIDYL HCL, Tablet, 1 mg (1/2 of 2 mg) may have potentially been mislabeled as the following drug:   PERPHENAZINE, Tablet, 16 mg, NDC 00781104901, Pedigree: AD73525_22, EXP: 5/30/2014.", "address_2": "", "product_quantity": "200 Tablets", "code_info": "TRIHEXYPHENIDYL HCL, Tablet, 1 mg (1/2 of 2 mg) has the following codes:   Pedigree: AD73525_34, EXP: 5/30/2014.", "center_classification_date": "20140120", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "TRIHEXYPHENIDYL HCL, Tablet, 1 mg (1/2 of 2 mg), Rx only, Distributed by: AidaPak Service, LLC, NDC 00591533501.", "report_date": "20140129", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-974-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65690", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup: azaTHIOprine, Tablet, 50 mg may have potentially been mislabeled as the following drug:  SELENIUM, Tablet, 50 mcg, NDC 00904316260, Pedigree: AD56939_1, EXP: 5/21/2014.", "address_2": "", "product_quantity": "100 Tablets", "code_info": "azaTHIOprine, Tablet, 50 mg has the following codes:   Pedigree: AD56832_1, EXP: 5/21/2014.", "center_classification_date": "20140120", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "azaTHIOprine, Tablet, 50 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00054408425.", "report_date": "20140129", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-797-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65690", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Wilson", "address_1": "4700 Sandoz Dr", "reason_for_recall": "Subpotent; Hydrochlorothiazide at the 9 month time point.", "address_2": "", "product_quantity": "2,491 bottles of 100 tablets each", "code_info": "Lot CU0856", "center_classification_date": "20131230", "distribution_pattern": "Nationwide", "state": "NC", "product_description": "Fosinopril Sodium and Hydrochlorothiazide Tablets, 10 mg/12.5 mg, Rx Only, 100 Tablets, Sandoz Inc. Princeton, NJ 08540 ---NDC 0185-0341-01,", "report_date": "20140108", "classification": "Class II", "openfda": {}, "recalling_firm": "Sandoz Inc", "recall_number": "D-393-2014", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "66554", "termination_date": "20150305", "more_code_info": "", "recall_initiation_date": "20131011", "postal_code": "27893-8143", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "East Bank Demerara", "state": "", "country": "Guyana", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "69206", "recalling_firm": "New Gpc Inc.", "address_1": "Lot A1, Farm", "address_2": "", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "New York", "recall_number": "D0033-2015", "product_description": "WHITFIELD LOTION, Net Contents: 60 mL.  Manufactured by: NEW GPC INC. A1 Farm, EBD.  Country of Origin Guyana.", "product_quantity": "360 units", "reason_for_recall": "Does Not Meet Monograph: NEW GPC INC. has recalled multiple Over-the-Counter Drug Products due to lack of drug listing, lack of OTC drug labeling requirements and labeled Not Approved for sale in U.S.A..", "recall_initiation_date": "20140807", "center_classification_date": "20141017", "termination_date": "20180604", "report_date": "20141029", "code_info": "Batch Numbers: 308289", "more_code_info": ""}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup; DISULFIRAM Tablet, 250 mg may be potentially mislabeled as    PYRIDOXINE HCL, Tablet, 50 mg, NDC 00904052060, Pedigree: AD22865_22, EXP: 5/2/2014.", "address_2": "", "product_quantity": "100 Tablets", "code_info": "DISULFIRAM Tablet, 250 mg has the following code    Pedigree: AD22609_1, EXP: 5/2/2014.", "center_classification_date": "20140116", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "DISULFIRAM Tablet, 250 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 64980017101", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-703-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65707", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup: DESMOPRESSIN ACETATE, Tablet 0.1 mg may have potentially been mislabeled as the following drug:   LOXAPINE, Capsule, 5 mg, NDC 00591036901, Pedigree: AD46426_7, EXP: 5/15/2014.", "address_2": "", "product_quantity": "98 Tablets", "code_info": "DESMOPRESSIN ACETATE, Tablet 0.1 mg has the following codes:   Pedigree: AD46426_16, EXP: 5/15/2014.", "center_classification_date": "20140120", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "DESMOPRESSIN ACETATE, Tablet 0.1 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00591246401.", "report_date": "20140129", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-968-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65690", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Pittsford", "state": "NY", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "65095", "recalling_firm": "American Lifestyle.Com", "address_1": "640 Kreag Rd Ste 101", "address_2": "N/A", "postal_code": "14534-3737", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Domestic distribution currently under Investigation; International distribution includes, but may not be limited to the following countries : Mexico, France, Brazil, Belgium, Denmark, Switzerland, Spain, Canada, Italy, Japan, Ireland, Venezuela, Oman.", "recall_number": "D-1223-2014", "product_description": "Vicerex A Powerful And Fast Acting Male Sexual Enhancer, 10 capsules per box, Dietary Supplement.  UPC 893490820087 (product numbers may possibly vary for same product identification and same product packaging), distributed by Vicerex.com.", "product_quantity": "13 boxes distributed domestically & 50 boxes distributed internationally to consumers", "reason_for_recall": "Marketed without an Approved NDA/ANDA: Laboratory analysis conducted by the FDA has determined the Vicerex product contains undeclared tadalafil and the Black Ant product contains undeclared sildenafil.   Tadalafil and sildenafil are FDA-Approved drugs used to treat male erectile dysfunction (ED), making the Vicerex and the Black Ant products unapproved new drugs.", "recall_initiation_date": "20130430", "center_classification_date": "20140407", "termination_date": "20180627", "report_date": "20140416", "code_info": "All lots, UPC 893490820087"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling:Label Mixup; MIRTAZAPINE Tablet, 7.5 mg may be potentially mislabeled as    BROMOCRIPTINE MESYLATE, Tablet, 2.5 mg, NDC 00574010603, Pedigree: AD73525_40, EXP: 5/30/2014;  DULoxetine HCl DR, Capsule, 20 mg, NDC 00002323560, Pedigree: W003005, EXP: 6/11/2014;  carBAMazepine ER, Tablet, 100 mg, NDC 00078051005, Pedigree: W003330, EXP: 6/18/2014.", "address_2": "", "product_quantity": "91 Tablets", "code_info": "MIRTAZAPINE, Tablet, 7.5 mg has the following codes    Pedigree: AD73525_55, EXP: 5/30/2014;  Pedigree: W003012, EXP: 6/11/2014;  Pedigree: W003334, EXP: 6/18/2014.", "center_classification_date": "20140116", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "MIRTAZAPINE Tablet, 7.5 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 59762141503", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-645-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65707", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Peapack", "state": "NJ", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "67637", "recalling_firm": "Greenstone Llc", "address_1": "100 Route 206 North", "address_2": "N/A", "postal_code": "07977", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide and Puerto Rico", "recall_number": "D-1361-2014", "product_description": "Venlafaxine HCl Extended-Release Capsules, 150 mg, 90-count Unit of Use bottles, Rx only, Distributed by: Greenstone LLC, Peapack, NJ  07977, NDC 59762-0182-2, UPC 3 59762-0182-2 9.", "product_quantity": "16,018 bottles", "reason_for_recall": "Presence of Foreign Tablets/Capsules: report of a foreign capsule with markings (TKN 250) and identified as a Tikosyn (dofetilide) capsule was found in a bottle of Effexor XR (venlafaxine HCl) 150 mg capsules that was packaged in the same packaging campaign as the recalled lot", "recall_initiation_date": "20140306", "center_classification_date": "20140609", "termination_date": "20170510", "report_date": "20140618", "code_info": "V130014, Exp 08/15"}, {"country": "United States", "city": "South Lyon", "address_1": "350 S Lafayette St", "reason_for_recall": "Lack of Assurance of Sterility: All unexpired sterile compounded human and veterinary products are being recalled because they were compounded in the same environment and under the same practices as another product found to be non-sterile and therefore sterility cannot be assured.", "address_2": "", "product_quantity": "70 mL", "code_info": "All unexpired lots, manufactured and distributed between 07/01/2013 and 10/19/2013; including Lot #s: 09112013@1, 09232013@40, t09252013@26", "center_classification_date": "20140110", "distribution_pattern": "Hospitals, clinics, physicians, and patients in the Michigan area only.", "state": "MI", "product_description": "DEXAMETHASONE NAPO4* PF 4MG/ML SOLUTION, all sizes, Rx only, Specialty Medicine Compounding Pharmacy, 350 S Lafayette, South Lyon, MI  48178", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Specialty Medicine Compounding Pharmacy", "recall_number": "D-417-2014", "initial_firm_notification": "Press Release", "product_type": "Drugs", "event_id": "66566", "termination_date": "20140922", "more_code_info": "", "recall_initiation_date": "20131019", "postal_code": "48178-1814", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup; VITAMIN B COMPLEX PROLONGED RELEASE, Tablet, 50 mg may be potentially mislabeled as    COENZYME Q-10, Capsule, 100 mg, NDC 37205055065, Pedigree: AD30180_16, EXP: 5/9/2014;  DOCUSATE SODIUM, Capsule, 50 mg, NDC 67618010060, Pedigree: AD60211_8, EXP: 5/21/2014;  ASPIRIN EC, Tablet, 325 mg, NDC 00904201360, Pedigree: AD39588_1, EXP: 5/13/2014.", "address_2": "", "product_quantity": "182 Tablets", "code_info": "VITAMIN B COMPLEX PROLONGED RELEASE Tablet, 50 mg has the following codes    Pedigree: AD30180_19, EXP: 5/9/2014;  Pedigree: AD60211_20, EXP: 5/21/2014;  Pedigree: AD39588_10, EXP: 5/13/2014.", "center_classification_date": "20140116", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "VITAMIN B COMPLEX PROLONGED RELEASE Tablet, 50 mg, Over The Counter, Distributed by: AidaPak Service, LLC, NDC 40985022251", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-552-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65707", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "New York", "state": "NY", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["NDA011757"], "brand_name": ["DEPO-MEDROL"], "generic_name": ["METHYLPREDNISOLONE ACETATE"], "manufacturer_name": ["Pharmacia & Upjohn Company LLC"], "product_ndc": ["0009-3073", "0009-3475"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRA-ARTICULAR", "INTRALESIONAL", "INTRAMUSCULAR", "SOFT TISSUE", "INTRASYNOVIAL"], "substance_name": ["METHYLPREDNISOLONE ACETATE"], "rxcui": ["1743779", "1743781", "1743855", "1743856"], "spl_id": ["befd723e-d1e2-41b9-83f1-17bca0c2a941", "bdefc300-8d7c-474c-9771-200628f25035"], "spl_set_id": ["9a7b3837-e038-48bf-97e9-78ad463760dc", "bf1b104d-85cb-414d-a366-78068c82c883"], "package_ndc": ["0009-3073-01", "0009-3073-03", "0009-3475-01", "0009-3475-03", "0009-3073-22", "0009-3073-23", "0009-3475-22", "0009-3475-23"], "is_original_packager": [true], "upc": ["0300093073036"], "unii": ["43502P7F0P"]}, "product_type": "Drugs", "event_id": "68876", "recalling_firm": "Pfizer Inc.", "address_1": "235 East 42nd Street", "address_2": "N/A", "postal_code": "10017-5703", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-1537-2014", "product_description": "Depo-Medrol (methylprednisolone acetate injectable suspension USP), 40 mg/ mL, 1 mL Single-Dose Vial, Rx only, Distributed by Pharmacia & Upjohn Co Division of Pfizer Inc, New York NY 10017  NDC 0009-3073-03    DEPO-MEDROL methylprednisolone acetate Injectable Suspension USP, 40 mg per mL,  1 mL Single-Dose Vial, Rx ONLY, Distributed by Pharmacia & Upjohn Co Division of Pfizer Inc, New York NY 10017, NOVAPLUS is a registered trademark of Novation, LLC NDC 0009-3073-23", "product_quantity": "93,800 vials", "reason_for_recall": "Failed pH Specification: A pH result of 2.9 was obtained at the 9 month stability test interval at 25C/60%RH. The registered specification for pH is 3.0 - 7.0", "recall_initiation_date": "20140730", "center_classification_date": "20140812", "termination_date": "20170322", "report_date": "20140820", "code_info": "Lot  H43272,  H43265 Exp. 09/14"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup; QUINAPRIL Tablet, 40 mg may be potentially mislabeled as    PROPRANOLOL HCL, Tablet, 10 mg, NDC 16714002104, Pedigree: AD52778_73, EXP: 5/21/2014.", "address_2": "", "product_quantity": "90 Tablets", "code_info": "QUINAPRIL Tablet, 40 mg has the following code    Pedigree: AD52778_76, EXP: 5/21/2014.", "center_classification_date": "20140116", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "QUINAPRIL Tablet, 40 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 31722027090", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-544-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65707", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Rockford", "state": "IL", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "68787", "recalling_firm": "Mylan Institutional, Inc. (d.b.a. UDL Laboratories)", "address_1": "1718 Northrock Ct", "address_2": "N/A", "postal_code": "61103-1201", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide, Puerto Rico, and Guam.", "recall_number": "D-1435-2014", "product_description": "Diltiazem HCl Extended-release Capsules, USP, 120 mg, packaged in 80 Capsules (8 x 10) blister cards per carton, Rx only, Manufactured by: Mylan Pharmaceuticals Inc., Morgantown, WV  26505, NDC 51079-947-08.", "product_quantity": "1,184 cartons", "reason_for_recall": "Failed Impurities/Degradation Specifications: High out-of-specification results for a related compound obtained during routine stability testing.", "recall_initiation_date": "20140703", "center_classification_date": "20140717", "termination_date": "20160726", "report_date": "20140723", "code_info": "Lot #: 3045659, 3048256, Exp 07/14"}, {"status": "Terminated", "city": "Deltona", "state": "FL", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "67471", "recalling_firm": "MyNicNaxs, Inc.", "address_1": "1012 Alpine Dr", "address_2": "N/A", "postal_code": "32725-7204", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide", "recall_number": "D-1372-2014", "product_description": "JIANFEIJINDAN Activity Girl Capsules, 400 mg, supplied in 30 count boxes, distributed by MyNicKnaxs, LLC, Deltona, FL", "product_quantity": "unknown", "reason_for_recall": "Marketed Without an Approved NDA/ANDA: Product was found to contain undeclared ingredient: N-di-desmethylsibutramine, an analog of sibutramine", "recall_initiation_date": "20140124", "center_classification_date": "20140612", "termination_date": "20191002", "report_date": "20140618", "code_info": "ALL LOTS"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup: PREGABALIN, Capsule, 200 mg may have potentially been mislabeled as one of the following drugs:  LOSARTAN POTASSIUM, Tablet, 50 mg, NDC 00781570192, Pedigree: AD21965_10, EXP: 5/1/2014;  CYANOCOBALAMIN, Tablet, 500 mcg, NDC 00536355101, Pedigree: AD30180_25, EXP: 5/9/2014;  clonazePAM, Tablet, 0.25 mg (1/2 of 0.5 mg), NDC 00093083201, Pedigree: AD73518_1, EXP: 5/31/2014;  OM", "address_2": "", "product_quantity": "540 Capsules", "code_info": "Labeling: Label Mixup: PREGABALIN, Capsule, 200 mg has the following codes:   Pedigree: AD21787_1, EXP: 5/1/2014;  Pedigree: AD30024_1, EXP: 5/9/2014;  Pedigree: AD73518_4, EXP: 5/31/2014;  Pedigree W002759, EXP: 6/6/2014;  Pedigree: W003397, EXP: 6/19/2014;  Pedigree: W003398, EXP: 6/19/2014.", "center_classification_date": "20140120", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "PREGABALIN, Capsule, 200 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00071101768.", "report_date": "20140129", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-806-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65690", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup; NICOTINE POLACRILEX Lozenge, 2 mg may be potentially mislabeled as    ASPIRIN DR EC, Tablet, 81 mg, NDC 00182106105, Pedigree: AD52433_1, EXP: 5/17/2014;  chlorproMAZINE HCl, Tablet, 100 mg, NDC 00832030300, Pedigree: AD70700_1, EXP: 5/29/2014;  CALCIUM ACETATE, Capsule, 667 mg, NDC 00054008826, Pedigree: AD73623_1, EXP: 5/30/2014;  FOLIC ACID, Tablet, 1 mg, NDC 65162036110,", "address_2": "", "product_quantity": "1,582 Lozenges", "code_info": "NICOTINE POLACRILEX Lozenge, 2 mg has the following codes    Pedigree: AD52433_4, EXP: 5/17/2014;  Pedigree: AD70700_4, EXP: 5/29/2014;  Pedigree: AD73623_7, EXP: 5/30/2014;  Pedigree: W003823, EXP: 6/27/2014;  Pedigree: W003463, EXP: 6/20/2014.", "center_classification_date": "20140116", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "NICOTINE POLACRILEX Lozenge, 2 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 37205098769", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-550-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65707", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup: SIMVASTATIN, Tablet, 40 mg may have potentially been mislabeled as the following drug:  METOPROLOL TARTRATE, Tablet, 12.5 mg (1/2 of 25 mg), NDC 63304057901, Pedigree: AD21790_67, EXP: 5/1/2014.", "address_2": "", "product_quantity": "90 Tablets", "code_info": "SIMVASTATIN, Tablet, 40 mg has the following codes:   Pedigree: AD22845_4, EXP: 5/2/2014.", "center_classification_date": "20140120", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "SIMVASTATIN, Tablet, 40 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00093715598.", "report_date": "20140129", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-842-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65690", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Irvine", "state": "CA", "country": "United States", "classification": "Class I", "openfda": {"application_number": ["NDA050779"], "brand_name": ["CEFAZOLIN SODIUM"], "generic_name": ["CEFAZOLIN SODIUM"], "manufacturer_name": ["B. Braun Medical Inc."], "product_ndc": ["0264-3103", "0264-3105", "0264-3107"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["CEFAZOLIN SODIUM"], "rxcui": ["1665050", "1665060", "2630753"], "spl_id": ["fb2f076a-22b3-46e0-86c8-7678e89c9edf"], "spl_set_id": ["17f8f038-c204-4dab-80d7-6f7ac41ddbec"], "package_ndc": ["0264-3103-11", "0264-3105-11", "0264-3107-11"], "is_original_packager": [true], "unii": ["P380M0454Z"]}, "product_type": "Drugs", "event_id": "66913", "recalling_firm": "B. Braun Medical Inc", "address_1": "2525 McGaw Ave", "address_2": "", "postal_code": "92614-5841", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide, Puerto Rico and Spain", "recall_number": "D-1269-2014", "product_description": "Cefazolin for Injection USP and Dextrose Injection USP, 2 g in Duplex,  50 mL Container, Catalog Number 3105-11, Rx Only, B Braun Medical Inc., Irvine CA 92614, NDC 0264-3105-11", "product_quantity": "42,576 units", "reason_for_recall": "Presence of Particulate Matter: B. Braun Medical Inc. is recalling several injectable products due to visible particulate matter found in reserve sample units.", "recall_initiation_date": "20131121", "center_classification_date": "20140425", "termination_date": "20141204", "report_date": "20140507", "code_info": "Lot# H2S723, Exp 07/14; H3H711, Exp 01/15", "more_code_info": ""}, {"status": "Terminated", "city": "Owens Cross Roads", "state": "AL", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "68671", "recalling_firm": "Poly Pharmaceuticals, Inc", "address_1": "2720 Cullom Blvd Se", "address_2": "N/A", "postal_code": "35763-9309", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S. Nationwide", "recall_number": "D-1431-2014", "product_description": "POLY-TUSSIN AC LIQUID, Each 5 mL (1 teaspoonful) contains: Brompheniramine Maleate 4 mg, Codeine Phosphate 10 mg, Phenylephrine HCl 7.5 mg, 16 fl oz. (473 mL) Bottle, Rx Only. Manufactured by: Great Southern Laboratories, Houston, TX 77099, Distributed for: Poly Pharmaceuticals, Mobile, AL  36619. NDC: 50991-713-16.", "product_quantity": "208 Bottles", "reason_for_recall": "Does Not Meet Monograph: Phenylephrine and pseudoephedrine are below monograph specifications, and label inaccurately contains wording \"Rx Only\".", "recall_initiation_date": "20140626", "center_classification_date": "20140711", "termination_date": "20141103", "report_date": "20140723", "code_info": "Lot #: 04413, Expiry: 02/15"}, {"status": "Terminated", "city": "Naperville", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "69152", "recalling_firm": "Martin Avenue Pharmacy, Inc.", "address_1": "1247 Rickert Dr", "address_2": "N/A", "postal_code": "60540-1008", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide", "recall_number": "D-0088-2015", "product_description": "Hydromorphone/clonidine/bupivacaine 12 mg/600 mcg/0.2 mg/mL injectable packaged in 30 mL or 60 mL syringes,  Martin Avenue Pharmacy, 1247 Rickert Dr, Naperville, IL.", "product_quantity": "40 mL", "reason_for_recall": "Lack of Assurance of Sterility: Martin Avenue Pharmacy, Inc. is conducting a voluntary recall of all compounded sterile preparations within expiry. The recall is being initiated in connection with a recent FDA inspection due to observations associated with certain quality control procedures that present a risk to sterility assurance.", "recall_initiation_date": "20140827", "center_classification_date": "20141029", "termination_date": "20180531", "report_date": "20141105", "code_info": "Lot Number: 08112014@55, Exp 9/10/2014", "more_code_info": ""}, {"status": "Terminated", "city": "Deerfield", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA019904"], "brand_name": ["POTASSIUM CHLORIDE"], "generic_name": ["POTASSIUM CHLORIDE"], "manufacturer_name": ["Baxter Healthcare Corporation"], "product_ndc": ["0338-0703", "0338-0705", "0338-0709"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["POTASSIUM CHLORIDE"], "rxcui": ["312507", "1860239", "1860241", "1860463", "1860466"], "spl_id": ["662e9982-ba6a-4787-98bd-7f03fbc6c6de"], "spl_set_id": ["092ddee4-572d-4771-8d95-880cea01097e"], "package_ndc": ["0338-0703-41", "0338-0703-48", "0338-0705-41", "0338-0705-48", "0338-0709-48"], "is_original_packager": [true], "unii": ["660YQ98I10"]}, "product_type": "Drugs", "event_id": "69518", "recalling_firm": "Baxter Healthcare Corp.", "address_1": "1 Baxter Pkwy", "address_2": "N/A", "postal_code": "60015-4625", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0256-2015", "product_description": "Potassium Chloride Injection, 10mEq per 100mL, 100 mL Sterile single dose container bags, Rx only, Baxter USA, NDC 0338-0709-48, Product Code 2B0826.", "product_quantity": "63,360 container bags", "reason_for_recall": "Labeling: Label Error On Declared Strength: Bags of Potassium Chloride 10 mEq per 100 mL were incorrectly overpouched with wraps labeled as Potassium Chloride Injection, 20 mEq per 100 mL.", "recall_initiation_date": "20141110", "center_classification_date": "20141121", "termination_date": "20161103", "report_date": "20141203", "code_info": "Lot #: P319160, Exp 06/30/15", "more_code_info": ""}, {"status": "Terminated", "city": "Toronto", "state": "", "country": "Canada", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "68967", "recalling_firm": "Apotex Inc.", "address_1": "150 Signet Drive", "address_2": "", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide and Puerto Rico", "recall_number": "D-1581-2014", "product_description": "PAXIL (Paroxetine HCL) Tablets 20 mg, 30-count bottle, Rx only, Manufactured by GlaxoSmithKline, RTP, NC 27709, Manufactured for Apotex Corp., Weston, FL 33328, NDC 60505-3664-3", "product_quantity": "", "reason_for_recall": "Chemical Contamination: Product were manufactured with active pharmaceutical ingredient (API) batches contaminated with residual materials and solvents.", "recall_initiation_date": "20140324", "center_classification_date": "20140903", "termination_date": "20140923", "report_date": "20140910", "code_info": "Lot # 2ZP5499, Exp. 02/15", "more_code_info": ""}, {"status": "Terminated", "city": "Wilsonville", "state": "OR", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "69519", "recalling_firm": "Oregon Compounding Centers, Inc. dba Creative Compounds", "address_1": "8560 Sw Salish Ln Ste 100", "address_2": "N/A", "postal_code": "97070-9625", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Oregon, Washington", "recall_number": "D-0194-2015", "product_description": "GLUTARALDEHYDE BUFFERED (POTASSIUM PHOSPHATE), solution for irrigation,  250 mL glass bottle, RX, Creative Compounds, Wilsonville, OR 97070", "product_quantity": "250 mL", "reason_for_recall": "Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.", "recall_initiation_date": "20141006", "center_classification_date": "20141031", "termination_date": "20150630", "report_date": "20141112", "code_info": "Lot #: 20140722@5, discard date: 10/20/2014;  Lot #: 20140723@45, discard date: 10/21/2014."}, {"status": "Terminated", "city": "Naperville", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "69152", "recalling_firm": "Martin Avenue Pharmacy, Inc.", "address_1": "1247 Rickert Dr", "address_2": "N/A", "postal_code": "60540-1008", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide", "recall_number": "D-0113-2015", "product_description": "PGE 2.5, 150 mcg/mL injectable packaged in a clear glass injectable vial, Martin Avenue Pharmacy, 1247 Rickert Dr, Naperville, IL.", "product_quantity": "160 mL", "reason_for_recall": "Lack of Assurance of Sterility: Martin Avenue Pharmacy, Inc. is conducting a voluntary recall of all compounded sterile preparations within expiry. The recall is being initiated in connection with a recent FDA inspection due to observations associated with certain quality control procedures that present a risk to sterility assurance.", "recall_initiation_date": "20140827", "center_classification_date": "20141029", "termination_date": "20180531", "report_date": "20141105", "code_info": "Lot Number: 07182014@28, Exp 9/15/2014", "more_code_info": ""}, {"status": "Terminated", "city": "Naperville", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "69152", "recalling_firm": "Martin Avenue Pharmacy, Inc.", "address_1": "1247 Rickert Dr", "address_2": "N/A", "postal_code": "60540-1008", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide", "recall_number": "D-0059-2015", "product_description": "Atropine sulfate 0.5% opthalmic solution packaged in a squeeze bottle eye dropper, Martin Avenue Pharmacy, 1247 Rickert Dr, Naperville, IL.", "product_quantity": "10 mL", "reason_for_recall": "Lack of Assurance of Sterility: Martin Avenue Pharmacy, Inc. is conducting a voluntary recall of all compounded sterile preparations within expiry. The recall is being initiated in connection with a recent FDA inspection due to observations associated with certain quality control procedures that present a risk to sterility assurance.", "recall_initiation_date": "20140827", "center_classification_date": "20141029", "termination_date": "20180531", "report_date": "20141105", "code_info": "Lot Number: 06062014@26, Exp 9/4/2014", "more_code_info": ""}, {"status": "Terminated", "city": "Grand Prairie", "state": "TX", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "65774", "recalling_firm": "Herbal Give Care Llc", "address_1": "1901 S Great Southwest Pkwy Ste 101", "address_2": "N/A", "postal_code": "75051-3557", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Products were sold to distributors nationwide. Recalling firm sold some product directly to consumers.", "recall_number": "D-1330-2014", "product_description": "Esbelin Siloutte Te, Suplemento Alimenticio, herbal tea in a gold foil/plastic zip-lock pouch. Hecho en Mexico Por: Herbal Give Care, Av Independencia # 1016, Fracc. La Rinconada, Aguascalientes, Ags. Mex. C.P. 20136.     UPC 7562684652553", "product_quantity": "311 pouches", "reason_for_recall": "Marketed Without an Approved NDA/ANDA: Products found to contain undeclared sibutramine, N-Desmethylsibutramine, and N-di-  Desmethylsibutramine. Sibutramine was removed from the U.S. market for safety reasons, making these products unapproved new drugs.", "recall_initiation_date": "20130719", "center_classification_date": "20140520", "termination_date": "20150821", "report_date": "20140528", "code_info": "All lots"}, {"country": "United States", "city": "Ocala", "address_1": "202 SW 17th St Suite C", "reason_for_recall": "Lack of Assurance of Sterility; All lots of sterile products compounded by the pharmacy within expiry are subject to this recall. This recall is initiated due to concerns associated with quality control procedures observed during a recent FDA inspection.", "address_2": "", "product_quantity": "8 units", "code_info": "Rx # 29096, Exp 05/20/14", "center_classification_date": "20140724", "distribution_pattern": "Florida", "state": "FL", "product_description": "Cubicin 600 mg/100 mL 0.9%NS, Trinity Care Solutions, 202-C SW 17th Street, Ocala, FL 34471-5138, For Parenteral Use Only, Rx # 29096, Discard After 05/20/14", "report_date": "20140730", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc dba Trinity Care Solutions", "recall_number": "D-1477-2014", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "product_type": "Drugs", "event_id": "68497", "more_code_info": "", "recall_initiation_date": "20140515", "postal_code": "34471-8138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Ongoing"}, {"status": "Terminated", "city": "Attleboro", "state": "MA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "68136", "recalling_firm": "Mangiacotti", "address_1": "117 Pleasant Street", "address_2": "N/A", "postal_code": "02703", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Nationwide", "recall_number": "D-1303-2014", "product_description": "Mangiacotti\t - Lemon Verbena Hand Sanitizer Spray, alcohol free, 0.5 fl. Oz., 15 mL spray bottle, UPC 870678005306, Active Ingredient Benzalkonium Chloride 0.1%, Dist by: Mangiacotti, Attleboro, MA 02703.", "product_quantity": "N/A", "reason_for_recall": "Microbial Contamination of Non-Sterile Products:  Elevated counts of bacteria was found, Serratia liquefaciens.", "recall_initiation_date": "20131227", "center_classification_date": "20140506", "termination_date": "20160429", "report_date": "20140514", "code_info": "Lot Code:  13348"}, {"country": "United States", "city": "Ocala", "address_1": "202 SW 17th St Suite C", "reason_for_recall": "Lack of Assurance of Sterility; All lots of sterile products compounded by the pharmacy within expiry are subject to this recall. This recall is initiated due to concerns associated with quality control procedures observed during a recent FDA inspection.", "address_2": "", "product_quantity": "21 units", "code_info": "Rx #28694, Exp 05/22/14", "center_classification_date": "20140724", "distribution_pattern": "Florida", "state": "FL", "product_description": "Impipenem/Cilastin (Primaxin) 500 mg/100 mL 0.9%NS, Trinity Care Solutions, 202-C SW 17th Street, Ocala, FL 34471-5138, For Parenteral Use Only, Rx #28694, Discard After 05/22/14", "report_date": "20140730", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc dba Trinity Care Solutions", "recall_number": "D-1465-2014", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "product_type": "Drugs", "event_id": "68497", "more_code_info": "", "recall_initiation_date": "20140515", "postal_code": "34471-8138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Ongoing"}, {"status": "Terminated", "city": "La Mirada", "state": "CA", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "68122", "recalling_firm": "Sung Soo Kim", "address_1": "14747 Artesia Blvd # 5c", "address_2": "N/A", "postal_code": "90638-6008", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "US nationwide and Korea", "recall_number": "D-1535-2014", "product_description": "Super ARTHGOLD 500mg, 120 Capsule Bottle, Dietary Supplement.  Manufactured for & Distributed by Nanowellbeing Health, Inc., 14747 Artesia Blvd, #5V, La Mirada, CA 90638.  UPC: 7 99475 35350 5.", "product_quantity": "6,336 bottles", "reason_for_recall": "Marketed Without an Approved NDA/ANDA; Product contains undeclared indomethacin, diclofenac, and chlorzoxazone.", "recall_initiation_date": "20140415", "center_classification_date": "20140808", "termination_date": "20140922", "report_date": "20140820", "code_info": "Lot #:  L1P1-6100 (expiry 6/25/2016) and L1P2-6000 (expiry 9/16/2016)."}, {"status": "Terminated", "city": "Naperville", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "69152", "recalling_firm": "Martin Avenue Pharmacy, Inc.", "address_1": "1247 Rickert Dr", "address_2": "N/A", "postal_code": "60540-1008", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide", "recall_number": "D-0082-2015", "product_description": "Glycerin 72% (w/v) sodium chloride injectable packaged in an amber glass injectable vial, Martin Avenue Pharmacy, 1247 Rickert Dr, Naperville, IL.", "product_quantity": "260 mL", "reason_for_recall": "Lack of Assurance of Sterility: Martin Avenue Pharmacy, Inc. is conducting a voluntary recall of all compounded sterile preparations within expiry. The recall is being initiated in connection with a recent FDA inspection due to observations associated with certain quality control procedures that present a risk to sterility assurance.", "recall_initiation_date": "20140827", "center_classification_date": "20141029", "termination_date": "20180531", "report_date": "20141105", "code_info": "Lot Number: 08072014@59, Exp 11/5/2014", "more_code_info": ""}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling:Label Mixup; DOCUSATE SODIUM Capsule, 100 mg may be potentially mislabeled as    DOCUSATE SODIUM, Capsule, 250 mg, NDC 00536375701, Pedigree: AD37063_4, EXP: 5/13/2014;  tiZANidine HCl, Tablet, 2 mg, NDC 00378072219, Pedigree: W002975, EXP: 6/11/2014.", "address_2": "", "product_quantity": "1,998 Capsules", "code_info": "DOCUSATE SODIUM, Capsule, 100 mg has the following codes    Pedigree: AD37063_1, EXP: 5/13/2014;  Pedigree: W002977, EXP: 6/11/2014.", "center_classification_date": "20140116", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "DOCUSATE SODIUM Capsule, 100 mg, Over The Counter, Distributed by: AidaPak Service, LLC,  NDC 57896040110", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-634-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65707", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup; LACTOBACILLUS GG Capsule, 10 Billion Cells may be potentially mislabeled as    guaiFENesin ER, Tablet, 600 mg, NDC 63824000815, Pedigree: AD21965_22, EXP: 5/1/2014.", "address_2": "", "product_quantity": "300 Cells", "code_info": "LACTOBACILLUS GG, Capsule, 10 Billion Cells has the following code    Pedigree: AD21965_19, EXP: 5/1/2014.", "center_classification_date": "20140116", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "LACTOBACILLUS GG Capsule, 10 Billion Cells, Over The Counter, Distributed by: AidaPak Service, LLC, NDC 49100036374", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-580-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65707", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup; NEOMYCIN SULFATE, Tablet, 500 mg may be potentially mislabeled as    IMIPRAMINE HCL, Tablet, 25 mg, NDC 00781176401, Pedigree: AD49448_10, EXP: 5/17/2014.", "address_2": "", "product_quantity": "100 Tablets", "code_info": "NEOMYCIN SULFATE, Tablet, 500 mg has the following code    Pedigree: AD49448_17, EXP: 5/17/2014.", "center_classification_date": "20140116", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "NEOMYCIN SULFATE Tablet, 500 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 51991073801", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-607-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65707", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Ocala", "address_1": "202 SW 17th St Suite C", "reason_for_recall": "Lack of Assurance of Sterility; All lots of sterile products compounded by the pharmacy within expiry are subject to this recall. This recall is initiated due to concerns associated with quality control procedures observed during a recent FDA inspection.", "address_2": "", "product_quantity": "", "code_info": "Rx # 28839, Exp 05/5/15; Rx # 29136, Exp 05/8/15", "center_classification_date": "20140724", "distribution_pattern": "Florida", "state": "FL", "product_description": "Normal Saline 10 mL/10 mL Syringe, Trinity Care Solutions, 202-C SW 17th Street, Ocala, FL 34471-5138, Rx # 28839, Discard After 05/5/15; Rx # 29163, Discard After 05/8/15", "report_date": "20140730", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc dba Trinity Care Solutions", "recall_number": "D-1468-2014", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "product_type": "Drugs", "event_id": "68497", "more_code_info": "", "recall_initiation_date": "20140515", "postal_code": "34471-8138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Ongoing"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup; TRIMETHOBENZAMIDE HCl, Capsule, 300 mg may be potentially mislabeled as    GABAPENTIN, Tablet, 600 mg, NDC 00228263611, Pedigree: AD21965_7, EXP: 5/1/2014;  CHOLECALCIFEROL, Capsule, 5000 units, NDC 00904598660, Pedigree: AD70629_19, EXP: 5/29/2014;  SODIUM BICARBONATE, Tablet, 650 mg, NDC 64980018210, Pedigree: W002970, EXP: 6/11/2014.", "address_2": "", "product_quantity": "300 Capsules", "code_info": "TRIMETHOBENZAMIDE HCl, Capsule, 300 mg has the following codes    Pedigree: AD21858_10, EXP: 5/1/2014;  Pedigree: AD70625_1, EXP: 5/29/2014;  Pedigree: W002976, EXP: 6/11/2014.", "center_classification_date": "20140116", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "TRIMETHOBENZAMIDE HCl Capsule, 300 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 53489037601", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-612-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65707", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Ferndale", "state": "WA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "67723", "recalling_firm": "Terra-Medica Inc.", "address_1": "1465 Slater Rd", "address_2": "N/A", "postal_code": "98248-8919", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Products were distributed US Nationwide, to Canada, to Philippines, and through internet sales.", "recall_number": "D-1191-2014", "product_description": "Pleo Not OINTMENT 3X, 30 g Tube, Topical Homeopathic Medicine, OTC Only. Made in Germany, Distributed by: SANUM USA Corp.,1465 Slater Road, Fernadale, WA 98248;  Manufactured By: SANUM-Kehlbeck GmbH & Co. KG. NDC: 49807-2305-1.", "product_quantity": "1368  tubes", "reason_for_recall": "Penicillin Cross Contamination", "recall_initiation_date": "20140303", "center_classification_date": "20140407", "termination_date": "20140730", "report_date": "20140416", "code_info": "Batch # 03051, EXP: April 2014; Batch # 13072, EXP: June 2015; Batch  #21033, EXP: April 2016."}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup: LEVOTHYROXINE SODIUM, Tablet, 137 mcg may have potentially been mislabeled as the following drug:  OMEGA-3 FATTY ACID, Capsule, 1000 mg, NDC 40985022921, Pedigree: AD21846_1, EXP: 5/1/2014.", "address_2": "", "product_quantity": "90 Tablets", "code_info": "LEVOTHYROXINE SODIUM, Tablet, 137 mcg has the following codes:   Pedigree: AD22616_10, EXP: 5/2/2014.", "center_classification_date": "20140120", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "LEVOTHYROXINE SODIUM, Tablet, 137 mcg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00781519192.", "report_date": "20140129", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-1010-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65690", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Horsham", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA088487"], "brand_name": ["HYDROXYZINE PAMOATE"], "generic_name": ["HYDROXYZINE PAMOATE"], "manufacturer_name": ["Teva Pharmaceuticals USA, Inc."], "product_ndc": ["0555-0302", "0555-0323", "0555-0324"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["HYDROXYZINE PAMOATE"], "rxcui": ["995232", "995253", "995278"], "spl_id": ["c307ca43-d41f-401b-bd15-0c753eca86e5"], "spl_set_id": ["06068fff-2e79-4721-bcc7-b0938aa20e7a"], "package_ndc": ["0555-0323-02", "0555-0323-04", "0555-0302-02", "0555-0302-04", "0555-0324-02"], "is_original_packager": [true], "upc": ["0305550302025", "0305550323020"], "unii": ["M20215MUFR"]}, "product_type": "Drugs", "event_id": "67412", "recalling_firm": "Teva Pharmaceuticals USA", "address_1": "425 Privet Rd", "address_2": "", "postal_code": "19044-1220", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide.", "recall_number": "D-1095-2014", "product_description": "Teva Hydroxyzine Pamoate Capsules, USP, 25 mg, 100- count bottle, Rx Only,Distributed by Teva Pharmaceuticals, USA, Sellersville, PA. NDC 0555-0323-02.", "product_quantity": "35746 capsules", "reason_for_recall": "CGMP Deviations: Hydroxyzine Pamoate Capsules, USP, 25 mg were manufactured using an unapproved material: API was incorrectly released for use in manufacturing.", "recall_initiation_date": "20140124", "center_classification_date": "20140228", "termination_date": "20141008", "report_date": "20140312", "code_info": "Lot #  34016752A, Exp. 09/16.   Lot #  34016753A, Exp. 09/16.", "more_code_info": ""}, {"country": "United States", "city": "Asheville", "address_1": "752 Biltmore Ave", "reason_for_recall": "Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.", "address_2": "", "product_quantity": "", "code_info": "All lot numbers within expiry.", "center_classification_date": "20140304", "distribution_pattern": "NC", "state": "NC", "product_description": "Triamcinolone Acetonide 3mg/ml", "report_date": "20140312", "classification": "Class II", "openfda": {}, "recalling_firm": "Natures Pharmacy & Compounding Center", "recall_number": "D-1139-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "66856", "termination_date": "20140424", "more_code_info": "", "recall_initiation_date": "20131101", "postal_code": "28803-2558", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Horsham", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA076001"], "brand_name": ["FLUOXETINE"], "generic_name": ["FLUOXETINE"], "manufacturer_name": ["Teva Pharmaceuticals USA, Inc."], "product_ndc": ["50111-647", "50111-648"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["FLUOXETINE HYDROCHLORIDE"], "rxcui": ["310384", "310385"], "spl_id": ["424ed364-e023-472f-b113-673e9342a7f1"], "spl_set_id": ["06d71a33-5578-4012-b11d-764f45bc1e6a"], "package_ndc": ["50111-647-01", "50111-647-02", "50111-647-03", "50111-648-01", "50111-648-02", "50111-648-03", "50111-648-44"], "is_original_packager": [true], "unii": ["I9W7N6B1KJ"], "upc": ["350111647015"]}, "product_type": "Drugs", "event_id": "67563", "recalling_firm": "Teva Pharmaceuticals USA", "address_1": "425 Privet Rd", "address_2": "", "postal_code": "19044-1220", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide and Puerto Rico", "recall_number": "D-1281-2014", "product_description": "Fluoxetine Capsules USP, 10 mg, 100-count bottles, Rx only, Manufactured in Poland By: Pliva Krakow Pharmaceutical Company S.A., Krakow, Poland; Manufactured For: Teva Pharmaceuticals USA, Sellersville, PA  18960, NDC 50111-647-01, UPC 3 50111-647-01 5.", "product_quantity": "72,356 bottles", "reason_for_recall": "Chemical Contamination: Recall due to a customer complaint trend regarding capsule odor.", "recall_initiation_date": "20140212", "center_classification_date": "20140428", "termination_date": "20141215", "report_date": "20140507", "code_info": "Lot #: 6A211158, 6A211159, 6A211163, Exp 11/15", "more_code_info": ""}, {"status": "Terminated", "city": "Ferndale", "state": "WA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "67723", "recalling_firm": "Terra-Medica Inc.", "address_1": "1465 Slater Rd", "address_2": "N/A", "postal_code": "98248-8919", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Products were distributed US Nationwide, to Canada, to Philippines, and through internet sales.", "recall_number": "D-1192-2014", "product_description": "Pleo Not SUPPOSITORIES 3X, 10 Suppository Cartons, Homeopathic Medicine, OTC Only. Made in Germany, Distributed by: SANUM USA Corp.,1465 Slater Road, Fernadale, WA 98248;  Manufactured By: SANUM-Kehlbeck GmbH & Co. KG. NDC: 49807-2304-1.", "product_quantity": "4860 cartons", "reason_for_recall": "Penicillin Cross Contamination", "recall_initiation_date": "20140303", "center_classification_date": "20140407", "termination_date": "20140730", "report_date": "20140416", "code_info": "Batch # 1080, EXP: July 2015; Batch # 1102, EXP: Septempber 2017."}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup: METHOCARBAMOL, Tablet, 500 mg may have potentially been mislabeled as the following drug:  LOSARTAN POTASSIUM, Tablet, 25 mg, NDC 00093736498, Pedigree: AD46312_16, EXP: 5/16/2014.", "address_2": "", "product_quantity": "100 Tablets", "code_info": "METHOCARBAMOL, Tablet, 500 mg has the following codes:   Pedigree: AD46312_28, EXP: 5/16/2014.", "center_classification_date": "20140120", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "METHOCARBAMOL, Tablet, 500 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00143129001.", "report_date": "20140129", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-866-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65690", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup; PRAMIPEXOLE DI-HCL, Tablet, 0.25 mg may be potentially mislabeled as    TACROLIMUS, Capsule, 1 mg, NDC 00781210301, Pedigree: W003704, EXP: 6/26/2014.", "address_2": "", "product_quantity": "90 Tablets", "code_info": "PRAMIPEXOLE DI-HCL Tablet, 0.25 mg has the following code    Pedigree: W003761, EXP: 6/26/2014.", "center_classification_date": "20140116", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "PRAMIPEXOLE DI-HCL Tablet, 0.25 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 16714058501", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-521-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65707", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup; ISOMETHEPTENE MUCATE/ DICHLORALPHENAZONE/APAP Capsule, 65 mg/100 mg/325 mg may be potentially mislabeled as    ALBUTEROL SULFATE ER, Tablet, 4 mg, NDC 00378412201, Pedigree: W003578, EXP: 6/24/2014;  LOSARTAN POTASSIUM, Tablet, 25 mg, NDC 16714058102, Pedigree: AD22616_7, EXP: 5/2/2014.", "address_2": "", "product_quantity": "200 Capsules", "code_info": "ISOMETHEPTENE MUCATE/ DICHLORALPHENAZONE/APAP, Capsule, 65 mg/100 mg/325 mg has the following codes    Pedigree: W003596, EXP: 5/31/2014;  Pedigree: AD22858_1, EXP: 3/31/2014.", "center_classification_date": "20140116", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "ISOMETHEPTENE MUCATE/ DICHLORALPHENAZONE/APAP Capsule, 65 mg/100 mg/325 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 44183044001", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-567-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65707", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Vancouver", "address_1": "11101 Ne 37th Cir", "reason_for_recall": "First Aid Only, Inc is recalling Smart Tab First Aid ezRefill System Ibuprofen boxes  and First Aid Cabinets containing these Ibuprofen boxes.  Ibuprofen boxes (FAE 7014) were accidentally used to package  aspirin packs  (10 packs of 2 / 235mg tablets).", "address_2": "", "product_quantity": "802", "code_info": "Aspirin was packed into Ibuprofen boxes (Item Number FAE-7014)  coded: B11340515, B11840515, B12040615, B12540615, B12640615, B12740615, C10340615 and B11040516.", "center_classification_date": "20140515", "distribution_pattern": "Nationwide", "state": "WA", "product_description": "Smart Tab First Aid ezRefill System Ibuprofen dispenser boxes (Item Number FAE 7014), 20 count boxes, First Aid Only Inc., Vancouver, WA", "report_date": "20140521", "classification": "Class II", "openfda": {}, "recalling_firm": "First Aid Only Inc", "recall_number": "D-1323-2014", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "product_type": "Drugs", "event_id": "67846", "termination_date": "20160411", "more_code_info": "", "recall_initiation_date": "20140325", "postal_code": "98682-7217", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "South Lyon", "address_1": "350 S Lafayette St", "reason_for_recall": "Lack of Assurance of Sterility: All unexpired sterile compounded human and veterinary products are being recalled because they were compounded in the same environment and under the same practices as another product found to be non-sterile and therefore sterility cannot be assured.", "address_2": "", "product_quantity": "160 grams", "code_info": "All unexpired lots, manufactured and distributed between 07/01/2013 and 10/19/2013; including Lot #s: 08132013@1, 08162013@5", "center_classification_date": "20140110", "distribution_pattern": "Hospitals, clinics, physicians, and patients in the Michigan area only.", "state": "MI", "product_description": "Aluminum Potassium Sulfate Sterile powder, Rx only, Specialty Medicine Compounding Pharmacy, 350 S Lafayette, South Lyon, MI  48178", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Specialty Medicine Compounding Pharmacy", "recall_number": "D-411-2014", "initial_firm_notification": "Press Release", "product_type": "Drugs", "event_id": "66566", "termination_date": "20140922", "more_code_info": "", "recall_initiation_date": "20131019", "postal_code": "48178-1814", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Asheville", "address_1": "752 Biltmore Ave", "reason_for_recall": "Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.", "address_2": "", "product_quantity": "", "code_info": "All lot numbers within expiry.", "center_classification_date": "20140304", "distribution_pattern": "NC", "state": "NC", "product_description": "Tacrolimus (H20-based) 0.03% ophth.", "report_date": "20140312", "classification": "Class II", "openfda": {}, "recalling_firm": "Natures Pharmacy & Compounding Center", "recall_number": "D-1134-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "66856", "termination_date": "20140424", "more_code_info": "", "recall_initiation_date": "20131101", "postal_code": "28803-2558", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup: CapsuleTOPRIL, Tablet, 25 mg may have potentially been mislabeled as the following drug:  DULoxetine HCl DR, Capsule, 20 mg, NDC 00002323560, Pedigree AD54587_4, EXP: 5/21/2014.", "address_2": "", "product_quantity": "99 Tablets", "code_info": "CapsuleTOPRIL, Tablet, 25 mg has the following codes:   Pedigree: AD52778_19, EXP: 5/20/2014.", "center_classification_date": "20140120", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "CapsuleTOPRIL, Tablet, 25 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00143117201.", "report_date": "20140129", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-865-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65690", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup: BUMETANIDE, Tablet, 0.5 mg, Rx only may have potentially been mislabeled as the following drug:  ERYTHROMYCIN DR EC, Tablet, 250 mg, NDC 24338012213, Pedigree: AD46426_13, EXP: 5/15/2014.", "address_2": "", "product_quantity": "100 Tablets", "code_info": "BUMETANIDE, Tablet, 0.5 mg, Rx only has the following codes:   Pedigree: AD46426_25, EXP: 5/15/2014.", "center_classification_date": "20140120", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "BUMETANIDE, Tablet, 0.5 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00093423201.", "report_date": "20140129", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-837-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65690", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Earth City", "state": "MO", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA076001"], "brand_name": ["FLUOXETINE"], "generic_name": ["FLUOXETINE"], "manufacturer_name": ["Legacy Pharmaceutical Packaging, LLC"], "product_ndc": ["68645-130", "68645-131"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["FLUOXETINE HYDROCHLORIDE"], "rxcui": ["310384", "310385"], "spl_id": ["308ede27-975d-f2aa-e063-6294a90a2213"], "spl_set_id": ["b07f9eab-44ac-4667-bd46-52d736daa5d6"], "package_ndc": ["68645-131-54", "68645-130-54"], "original_packager_product_ndc": ["50111-647", "50111-648"], "upc": ["0368645130545", "368645130545"], "unii": ["I9W7N6B1KJ"]}, "product_type": "Drugs", "event_id": "67526", "recalling_firm": "Legacy Pharmaceutical Packaging", "address_1": "13333 Lakefront Dr", "address_2": "", "postal_code": "63045-1514", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Nationwide", "recall_number": "D-1279-2014", "product_description": "Fluoxetine Capsules, USP, 20 mg, 30-count bottles, Rx only, Distributed by: Wal-Mart, Bentonville, AR  72716; Manufactured by: TEVA PHARMACEUTICALS USA, Sellersville, PA  18960; Packaged by: Legacy Pharmaceutical Packaging LLC, Earth City, MO  63045, NDC 68645-130-54, UPC 3 68645 13054 5.", "product_quantity": "667,068 bottles", "reason_for_recall": "Chemical Contamination: The recalling firm received notice that their supplier is recalling capsules due to complaints of capsules having an unusual odor.", "recall_initiation_date": "20140214", "center_classification_date": "20140428", "termination_date": "20171127", "report_date": "20140507", "code_info": "Lot numbers: 131328, Exp 08/15; 131634, Exp 09/15; and 131833, Exp 11/15", "more_code_info": ""}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup; FLUoxetine HCl, Capsule, 10 mg may be potentially mislabeled as    PANCRELIPASE DR, Capsule, 24000 /76000 /120000 USP units, NDC 00032122401, Pedigree: AD70585_10, EXP: 5/29/2014.", "address_2": "", "product_quantity": "100 Capsules", "code_info": "FLUoxetine HCl, Capsule, 10 mg has the following code    Pedigree: AD70585_13, EXP: 5/29/2014.", "center_classification_date": "20140116", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "FLUoxetine HCl Capsule, 10 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 16714035103", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-517-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65707", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Naperville", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "69152", "recalling_firm": "Martin Avenue Pharmacy, Inc.", "address_1": "1247 Rickert Dr", "address_2": "N/A", "postal_code": "60540-1008", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide", "recall_number": "D-0110-2015", "product_description": "Peng/proc/strep/chlor/hyos (penicillin G, procaine, streptomycin sulfate, chlorpheniramine maleate, hyoscyamine sulfate) (vet) injection suspension packaged in an amber glass injectable vial, Martin Avenue Pharmacy, 1247 Rickert Dr, Naperville, IL.", "product_quantity": "900 mL", "reason_for_recall": "Lack of Assurance of Sterility: Martin Avenue Pharmacy, Inc. is conducting a voluntary recall of all compounded sterile preparations within expiry. The recall is being initiated in connection with a recent FDA inspection due to observations associated with certain quality control procedures that present a risk to sterility assurance.", "recall_initiation_date": "20140827", "center_classification_date": "20141029", "termination_date": "20180531", "report_date": "20141105", "code_info": "Lot Number: 03312014@29, Exp 9/27/2014; 06262014@20, Exp 12/23/2014", "more_code_info": ""}]